Helen of Troy Limited (HELE) 10-Q 8 Jan 21 2021 Q3 Quarterly report Financial data

Cover page

Cover page - shares	9 Months Ended
	Nov. 30, 2020	Dec. 29, 2020
Entity Addresses [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Nov. 30, 2020
Document Transition Report	false
Entity File Number	001-14669
Entity Registrant Name	HELEN OF TROY LIMITED
Entity Incorporation, State or Country Code	D0
Entity Tax Identification Number	74-2692550
Entity Address, Address Line One	1 Helen of Troy Plaza
Entity Address, City or Town	El Paso
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	79912
City Area Code	915
Local Phone Number	225-8000
Title of 12(b) Security	Common Shares, $0.10 par value per share
Trading Symbol	HELE
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		24,395,784
Entity Central Index Key	0000916789
Current Fiscal Year End Date	--02-28
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false
Other Address
Entity Addresses [Line Items]
Entity Address, Address Line One	Clarendon House, 2 Church Street
Entity Address, City or Town	Hamilton
Entity Address, Country	BM

Consolidated Condensed Balance

Consolidated Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands	Nov. 30, 2020	Feb. 29, 2020
Assets, current:
Cash and cash equivalents	$ 156,661	$ 24,467
Receivables - principally trade, less allowances of $3,956 and $1,461	500,070	348,023
Inventory	383,440	256,311
Prepaid expenses and other current assets	10,591	9,229
Assets held for sale	39,306	44,806
Total assets, current	1,090,068	682,836
Property and equipment, net of accumulated depreciation of $144,462 and $132,340	135,795	132,107
Goodwill	739,901	739,901
Other intangible assets, net of accumulated amortization of $162,425 and $148,891	288,617	300,952
Operating lease assets	32,277	32,645
Deferred tax assets, net	21,568	14,635
Other assets, net of accumulated amortization of $2,167 and $2,167	3,518	807
Total assets	2,311,744	1,903,883
Liabilities, current:
Accounts payable, principally trade	301,175	152,674
Accrued expenses and other current liabilities	289,568	183,157
Income taxes payable	5,878	1,181
Long-term debt, current maturities	1,884	1,884
Total liabilities, current	598,505	338,896
Long-term debt, excluding current maturities	438,497	337,421
Lease liabilities, non-current	39,279	40,861
Deferred tax liabilities, net	5,636	4,224
Other liabilities, non-current	19,389	20,758
Total liabilities	1,101,306	742,160
Commitments and contingencies
Stockholders' equity:
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued	0	0
Common stock, $0.10 par. Authorized 50,000,000 shares; 24,394,007 and 25,193,766 shares issued and outstanding	2,439	2,519
Additional paid in capital	277,289	268,043
Accumulated other comprehensive loss	(12,285)	(7,005)
Retained earnings	942,995	898,166
Total stockholders' equity	1,210,438	1,161,723
Total liabilities and stockholders' equity	$ 2,311,744	$ 1,903,883

Consolidated Condensed Balanc_2

Consolidated Condensed Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Nov. 30, 2020	Feb. 29, 2020
Statement of Financial Position [Abstract]
Receivables - principally trade, allowances	$ 3,956	$ 1,461
Property and equipment, accumulated depreciation	144,462	132,340
Other intangible assets, accumulated amortization	162,425	148,891
Other assets, accumulated amortization	$ 2,167	$ 2,167
Cumulative preferred stock, non-voting, par (in dollars per share)	$ 1	$ 1
Cumulative preferred stock, non-voting, authorized shares (in shares)	2,000,000	2,000,000
Cumulative preferred stock, non-voting, issued shares (in shares)	0	0
Common stock, par (in dollars per share)	$ 0.10	$ 0.10
Common stock, authorized shares (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	24,394,007	25,193,766
Common stock, shares outstanding (in shares)	24,394,007	25,193,766

Consolidated Condensed Statemen

Consolidated Condensed Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019
Income Statement [Abstract]
Sales revenue, net	$ 637,737	$ 474,737	$ 1,589,424	$ 1,265,067
Cost of goods sold	350,410	264,764	892,460	723,216
Gross profit	287,327	209,973	696,964	541,851
Selling, general and administrative expense (“SG&A”)	186,630	130,692	439,646	359,794
Restructuring charges	(12)	12	355	1,061
Operating income	100,709	79,269	256,963	180,996
Non-operating income, net	93	92	440	313
Interest expense	(2,926)	(2,767)	(9,568)	(9,291)
Income before income tax	97,876	76,594	247,835	172,018
Income tax expense	13,721	7,895	16,061	16,530
Net income	$ 84,155	$ 68,699	$ 231,774	$ 155,488
Earnings per share (“EPS”):
Earnings per share - basic (in dollars per share)	$ 3.37	$ 2.73	$ 9.20	$ 6.19
Total earnings per share - diluted (in dollars per share)	$ 3.34	$ 2.71	$ 9.14	$ 6.15
Weighted average shares used in computing EPS:
Basic (in shares)	24,965	25,161	25,182	25,099
Diluted (in shares)	25,192	25,396	25,350	25,295

Consolidated Condensed Statem_2

Consolidated Condensed Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 84,155	$ 68,699	$ 231,774	$ 155,488
Other comprehensive income (loss), net of tax:
Cash flow hedge activity - interest rate swaps	1,180	1,599	(696)	(5,562)
Cash flow hedge activity - foreign currency contracts	855	(1,729)	(4,584)	(514)
Total other comprehensive income (loss), net of tax	2,035	(130)	(5,280)	(6,076)
Comprehensive income	$ 86,190	$ 68,569	$ 226,494	$ 149,412

Condensed Consolidated Statemen

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Beginning balance (in shares) at Feb. 28, 2019		24,946,000
Beginning balance at Feb. 28, 2019	$ 996,637	$ 2,495	$ 246,585	$ 1,191	$ 746,366
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	155,488				155,488
Other comprehensive income (loss), net of tax	(6,076)			(6,076)
Exercise of stock options (in shares)		69,000
Exercise of stock options	4,190	$ 7	4,183
Net issuance and settlement of restricted stock (in shares)		199,000
Net issuance and settlement of restricted stock	0	$ 21	(21)
Issuance of common stock related to stock purchase plan (in shares)		30,000
Issuance of common stock related to stock purchase plan	2,835	$ 2	2,833
Common stock repurchased and retired (in shares)		(77,000)
Common stock repurchased and retired	(10,133)	$ (8)	(9,592)		(533)
Share-based compensation	18,743		18,743
Ending balance (in shares) at Nov. 30, 2019		25,167,000
Ending balance at Nov. 30, 2019	1,161,684	$ 2,517	262,731	(4,885)	901,321
Beginning balance (in shares) at Aug. 31, 2019		25,130,000
Beginning balance at Aug. 31, 2019	1,087,375	$ 2,513	256,995	(4,755)	832,622
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	68,699				68,699
Other comprehensive income (loss), net of tax	(130)			(130)
Exercise of stock options (in shares)		7,000
Exercise of stock options	557	$ 1	556
Net issuance and settlement of restricted stock (in shares)		21,000
Net issuance and settlement of restricted stock	0	$ 3	(3)
Issuance of common stock related to stock purchase plan (in shares)		15,000
Issuance of common stock related to stock purchase plan	1,427	$ 1	1,426
Common stock repurchased and retired (in shares)		(6,000)
Common stock repurchased and retired	(1,002)	$ (1)	(1,001)		0
Share-based compensation	4,758		4,758
Ending balance (in shares) at Nov. 30, 2019		25,167,000
Ending balance at Nov. 30, 2019	1,161,684	$ 2,517	262,731	(4,885)	901,321
Beginning balance (in shares) at Feb. 29, 2020		25,194,000
Beginning balance at Feb. 29, 2020	1,161,723	$ 2,519	268,043	(7,005)	898,166
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	231,774				231,774
Other comprehensive income (loss), net of tax	$ (5,280)			(5,280)
Exercise of stock options (in shares)	13,540	13,000
Exercise of stock options	$ 917	$ 2	915
Net issuance and settlement of restricted stock (in shares)		189,000
Net issuance and settlement of restricted stock	0	$ 19	(19)
Issuance of common stock related to stock purchase plan (in shares)		27,000
Issuance of common stock related to stock purchase plan	3,611	$ 2	3,609
Common stock repurchased and retired (in shares)		(1,029,000)
Common stock repurchased and retired	(202,961)	$ (103)	(15,913)		(186,945)
Share-based compensation	20,654		20,654
Ending balance (in shares) at Nov. 30, 2020		24,394,000
Ending balance at Nov. 30, 2020	1,210,438	$ 2,439	277,289	(12,285)	942,995
Beginning balance (in shares) at Aug. 31, 2020		25,328,000
Beginning balance at Aug. 31, 2020	1,308,529	$ 2,533	274,643	(14,320)	1,045,673
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	84,155				84,155
Other comprehensive income (loss), net of tax	$ 2,035			2,035
Exercise of stock options (in shares)	850	1,000
Exercise of stock options	$ 70	$ 0	70
Net issuance and settlement of restricted stock (in shares)		20,000
Net issuance and settlement of restricted stock	0	$ 2	(2)
Issuance of common stock related to stock purchase plan (in shares)		12,000
Issuance of common stock related to stock purchase plan	1,710	$ 1	1,709
Common stock repurchased and retired (in shares)		(967,000)
Common stock repurchased and retired	(192,800)	$ (97)	(5,870)		(186,833)
Share-based compensation	6,739		6,739
Ending balance (in shares) at Nov. 30, 2020		24,394,000
Ending balance at Nov. 30, 2020	$ 1,210,438	$ 2,439	$ 277,289	$ (12,285)	$ 942,995

Consolidated Condensed Statem_3

Consolidated Condensed Statements of Cash Flows (Unaudited) $ in Thousands	9 Months Ended
	Nov. 30, 2020USD ($)	Nov. 30, 2019USD ($)
Cash provided by operating activities:
Net income	$ 231,774	$ 155,488
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	27,995	24,876
Amortization of financing costs	772	763
Non-cash operating lease expense	4,910	1,371
Provision for doubtful receivables	3,445	484
Non-cash share-based compensation	20,654	18,743
Loss (gain) on the sale or disposal of property and equipment	75	(14)
Deferred income taxes and tax credits	(4,132)	(511)
Changes in operating capital:
Receivables	(155,492)	(85,747)
Inventories	(121,629)	(31,317)
Prepaid expenses and other current assets	(2,915)	(1,269)
Other assets and liabilities, net	(6,617)	21,091
Accounts payable	148,501	(2,037)
Accrued expenses and other current liabilities	95,612	477
Accrued income taxes	6,793	(980)
Net cash provided by operating activities	249,746	101,418
Cash used in investing activities:
Capital and intangible asset expenditures	(19,423)	(13,247)
Proceeds from the sale of property and equipment	0	3
Net cash used in investing activities	(19,423)	(13,244)
Cash used in financing activities:
Proceeds from line of credit	917,400	406,600
Repayment of line of credit	(811,400)	(482,000)
Repayment of long-term debt	(1,900)	(1,900)
Payment of financing costs	(3,796)	0
Proceeds from share issuances under share-based compensation plans	4,528	7,025
Payments for repurchases of common stock	(202,961)	(10,133)
Net cash used in financing activities	(98,129)	(80,408)
Net increase in cash and cash equivalents	132,194	7,766
Cash and cash equivalents, beginning balance	24,467	11,871
Cash and cash equivalents, ending balance	156,661	$ 19,637
Supplemental non-cash items not included above resulting from the adoption of ASC 842
Initial recognition of lease liabilities	$ 44,049

Basis of Presentation and Relat

Basis of Presentation and Related Information	9 Months Ended
	Nov. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Related Information	Note 1 - Basis of Presentation and Related Information The accompanying condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly our consolidated financial position as of November 30, 2020 and February 29, 2020, and the results of our consolidated operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 29, 2020, and our other reports on file with the Securities and Exchange Commission (“SEC”). When used in these notes, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries. We refer to our common shares, par value $0.10 per share, as “common stock.” References to the “FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to United States (“U.S.”) Generally Accepted Accounting Principles. References to “ASU” refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB. References to “ASC” refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB. We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a global designer, developer, importer, marketer, and distributor of an expanding portfolio of brand-name consumer products. We have three segments: Housewares, Health & Home, and Beauty. Our Housewares segment provides a broad range of innovative consumer products for the home and on the go. Product offerings include food preparation tools and storage containers; cleaning, bath and garden tools and accessories; infant and toddler care products; and insulated beverage, food containers and coolers. The Health & Home segment focuses on health care devices such as thermometers, humidifiers, blood pressure monitors, and heating pads; water filtration systems; and small home appliances such as portable heaters, fans, and air purifiers. Our Beauty segment products include electric hair care, beauty care and wellness appliances; grooming tools and accessories; and liquid-, solid- and powder-based personal care and grooming products. Our business is seasonal due to different calendar events, holidays and seasonal weather patterns. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30th. We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico and the United States. On January 23, 2020, we completed the acquisition of Drybar Products LLC (“Drybar Products”), for approximately $255.9 million in cash, subject to certain customary closing adjustments. Drybar Products is an innovative, trend-setting prestige hair care and styling brand. As part of the transaction, Helen of Troy granted a worldwide license to Drybar Holdings LLC, the owner and long-time operator of Drybar blowout salons, to use the Drybar trademark in their continued operation of Drybar salons. The salons will exclusively use, promote, and sell Drybar products globally. See Note 7 for additional information on the acquisition. During the fourth quarter of fiscal 2020, we committed to a plan to divest certain assets within our mass channel personal care business (“Personal Care”). The assets to be disposed of include intangible assets, inventory and fixed assets relating to our mass channel liquids, powder and aerosol products including brands such as Pert, Brut, Sure and Infusium. We expect the divestiture to occur within fiscal 2021. Accordingly, we have classified the identified assets of the disposal group as held for sale. For additional information, see Note 5. In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (“COVID-19”) to be a pandemic. COVID-19 continues to spread throughout the United States and the world, with the continued potential for catastrophic impact. The effects of the COVID-19 pandemic have had an unfavorable impact on certain parts of our business. The impact includes the effect of temporary closures of certain customer stores, or limited hours of operation, which has resulted in materially lower store traffic at some of our brick and mortar retailers. The economic impact of historic unemployment and consumer uncertainty has also resulted in reduced demand for some of our more discretionary product lines. COVID-19 has also disrupted certain parts of our supply chain, which in certain cases has limited our ability to fulfill demand. COVID-19 has favorably impacted the demand for our product lines that are more defensive, meet certain healthcare or healthy living needs, or meet the needs of consumers that are spending more time at home as a result of the pandemic. COVID-19 has also favorably impacted our online channel in a meaningful way, as brick and mortar shopping options have been limited or considered unsafe. Although the favorable impacts of COVID-19 outweighed the unfavorable impacts during the nine month period ended November 30, 2020, this situation continues to change rapidly, and additional impacts or more pronounced adverse impacts may arise that we are not currently aware of today. Accordingly, our liquidity and financial results could be impacted in ways that we are not able to predict today. Our condensed consolidated financial statements are prepared in U.S. Dollars. All intercompany accounts and transactions are eliminated in consolidation. The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. The severity, duration and the economic consequences of COVID-19 are uncertain, evolving and difficult to predict. Therefore, our estimates and assumptions may change materially in future periods in response to COVID-19. Actual results may differ materially from those estimates. We have reclassified, combined or separately disclosed certain amounts in the prior years’ condensed consolidated financial statements and accompanying footnotes to conform with the current period’s presentation.

New Accounting Pronouncements

New Accounting Pronouncements	9 Months Ended
	Nov. 30, 2020
Accounting Changes and Error Corrections [Abstract]
New Accounting Pronouncements	Note 2 - New Accounting Pronouncements Except for the changes discussed below, there have been no changes in the information provided in our Form 10-K for the fiscal year ended February 29, 2020. Not Yet Adopted In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which provides for certain updates to reduce complexity in accounting for income taxes, including the utilization of the incremental approach for intra-period tax allocation, among others. The amendments in ASU 2019-12 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, and will be effective for us in the first quarter of fiscal 2022. We are currently evaluating the impact this guidance may have on our consolidated financial statements. Adopted In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting and other transactions affected by reference rate reform to ease the financial reporting burdens related to the expected market transition from the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates to alternative reference rates. This ASU was effective upon issuance, on March 12, 2020, and may be applied through December 31, 2022. The adoption of this ASU did not have a material impact on our consolidated financial statements. In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (with subsequent targeted amendments), which modifies the measurements of expected credit losses for certain financial instruments and financial assets, including trade receivables. This ASU was effective for us in the first quarter of fiscal 2021, and the adoption of this ASU did not have a material impact on our consolidated financial statements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement . ASU 2018-13 removes certain disclosures, modifies certain disclosures and adds additional disclosures. Certain disclosures in ASU 2018-13 would need to be applied on a retrospective basis and others on a prospective basis. This ASU was effective for us in the first quarter of fiscal 2021, and the adoption of this ASU did not have a material impact on our consolidated financial statements. In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract . ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This ASU was effective for us in the first quarter of fiscal 2021, and the adoption of this ASU did not have a material impact on our consolidated financial statements.

Revenue Recognition

Revenue Recognition	9 Months Ended
	Nov. 30, 2020
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Note 3 - Revenue Recognition We adopted the provisions of ASU 2014-09 in the first quarter of fiscal 2019, and we elected to adopt the standard using the retrospective method. The core principle of the guidance is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Our revenue is primarily generated from the sale of non-customized consumer products to customers. These products are promised goods that are distinct performance obligations. Revenue is recognized when control of, and title to, the product sold transfers to the customer in accordance with applicable shipping terms, which can occur on the date of shipment or the date of receipt by the customer, depending on the customer and the agreed upon shipping terms. Payment terms from the sale of our products are typically due to us in thirty to ninety days after the date of sale. Therefore, the timing and amount of revenue recognized was not materially impacted by the new guidance. We have thus concluded that the adoption of the guidance did not have a material impact on our consolidated financial statements. The provisions of the new guidance did, however, impact the classification of certain consideration paid to our customers. We therefore have reclassified an immaterial amount of such payments from SG&A to a reduction of net sales revenue for all periods presented. Also, in accordance with the guidance, we reclassified an immaterial amount of estimated sales returns from a reduction of receivables to accrued expenses and other current liabilities for all periods presented. We elected to adopt the guidance using the full retrospective method. We measure revenue as the amount of consideration for which we expect to be entitled, in exchange for transferring goods. Certain customers may receive cash incentives such as customer discounts (including volume or trade discounts), advertising discounts and other customer-related programs which are accounted for as variable consideration. In some cases, we apply judgment, such as contractual rates and historical payment trends, when estimating variable consideration. In accordance with the guidance, most variable consideration is classified as a reduction to net sales. Sales taxes and other similar taxes are excluded from revenue. We elected to account for shipping and handling activities as a fulfillment cost as permitted by the guidance. We do not have unsatisfied performance obligations since our performance obligations are satisfied at a single point in time.

Leases

Leases	9 Months Ended
	Nov. 30, 2020
Leases [Abstract]
Leases	Note 4 - Leases Adoption of the new lease standard resulted in the recording of lease assets and lease liabilities of approximately $37.1 million and $47.2 million, respectively, as of March 1, 2019. The difference between the lease assets and lease liabilities primarily relates to unamortized lease incentives and deferred rent recorded in accordance with the previous lease guidance. The new standard did not materially impact our consolidated statements of income or cash flows. We primarily have leases for office space, which are classified as operating leases. Operating leases are included in operating lease assets, accrued expenses and other current liabilities, and lease liabilities, non-current in our consolidated balance sheets. Operating lease assets and operating lease liabilities are recognized based on the present value of the future lease payments over the lease term at commencement date. As most of our lease contracts do not provide an explicit interest rate, we use an estimated secured incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We include options to extend or terminate the lease in the lease term for accounting considerations, when it is reasonably certain that we will exercise that option. Our leases have remaining lease terms of less than 1 to 12 years. Lease expense for lease payments is recognized on a straight-line basis over the lease term in a manner similar to previous accounting guidance. We do not recognize leases with an initial term of twelve months or less on the balance sheet and instead recognize the related lease payments as expense in the condensed consolidated statements of income on a straight-line basis over the lease term. We account for lease and non-lease components as a single lease component for all asset classes. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. Operating lease expense recognized in the condensed consolidated statements of income during the three and nine month periods ended November 30, 2020, was $1.8 million and $5.0 million, respectively, compared t o $1.5 million and $4.8 million, respectively, for the same periods last year. Short-term lease expense is excluded from this amount and is not material. For the three and nine month periods ended November 30, 2020, rent expense related to all our operating leases was $2.4 million and $6.6 million, respectively, compared to $2.1 million and $5.8 million for the same periods last year. The non-cash component of lease expense is included as an adjustment to reconcile net income to net cash provided by operating activities in the condensed consolidated statements of cash flows. A summary of supplemental lease information is as follows: November 30, 2020 Weighted average remaining lease term ( years ) 10.0 Weighted average discount rate 6.10% Year-to-date cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases (in thousands) $ 4,998 A summary of our estimated lease payments, imputed interest and liabilities as of November 30, 2020 are as follows: (in thousands) Fiscal 2021 (balance for remainder of fiscal year) $ 1,826 Fiscal 2022 7,128 Fiscal 2023 6,123 Fiscal 2024 5,332 Fiscal 2025 5,762 Thereafter 34,370 Total future lease payments 60,541 Less: imputed interest (16,492) Present value of lease liability $ 44,049 November 30, 2020 Lease liabilities, current (1) $ 4,770 Lease liabilities, non-current 39,279 Total lease liability $ 44,049

Assets Held for Sale

Assets Held for Sale	9 Months Ended
	Nov. 30, 2020
Property, Plant and Equipment [Abstract]
Assets Held for Sale	Note 5 - Assets Held for Sale During the fourth quarter of fiscal 2020, we committed to a plan to divest certain assets within Personal Care. The assets to be disposed of include intangible assets, inventory and fixed assets relating to our mass channel liquids, powder and aerosol products under brands such as Pert, Brut, Sure and Infusium. We expect the divestiture to occur within fiscal 2021 and have classified the identified assets of the disposal group as held for sale. The business is currently being marketed and the process is ongoing. The carrying amounts of the major classes of assets for Personal Care that were classified as held for sale are as follows: (in thousands) November 30, 2020 February 29, 2020 Assets: Inventory $ 11,650 $ 17,150 Property and equipment, net of accumulated depreciation of $403 83 83 Goodwill, net of cumulative impairments of $71,993 9,849 9,849 Other intangible assets, net of accumulated amortization of $4,474 17,724 17,724 Total assets held for sale $ 39,306 $ 44,806

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	9 Months Ended
	Nov. 30, 2020
Balance Sheet Related Disclosures [Abstract]
Supplemental Balance Sheet Information	Note 6 - Supplemental Balance Sheet Information PROPERTY AND EQUIPMENT (in thousands) Estimated November 30, 2020 February 29, 2020 Land - $ 12,644 $ 12,644 Building and improvements 3 - 40 117,061 115,592 Computer, software, furniture and other equipment 3 - 15 98,382 89,257 Tools, molds and other production equipment 3 - 7 43,001 37,652 Construction in progress - 9,169 9,302 Property and equipment, gross 280,257 264,447 Less accumulated depreciation (144,462) (132,340) Property and equipment, net $ 135,795 $ 132,107 ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (in thousands) November 30, 2020 February 29, 2020 Accrued compensation, benefits and payroll taxes $ 54,667 $ 49,624 Accrued sales discounts and allowances 55,832 34,176 Accrued sales returns 31,919 22,972 Accrued advertising 60,549 31,351 Other 86,601 45,034 Total accrued expenses and other current liabilities $ 289,568 $ 183,157

Acquisitions

Acquisitions	9 Months Ended
	Nov. 30, 2020
Business Combinations [Abstract]
Acquisitions	Note 7 - Acquisitions Drybar Products Acquisition On January 23, 2020, we completed the acquisition of Drybar Products for approximately $255.9 million in cash, subject to certain customary closing adjustments. Acquisition-related expenses incurred during fiscal 2020 were approximately $2.5 million before tax. The purchase price was funded by borrowings under the Company's revolving credit agreement. Drybar is an innovative, trend-setting prestige hair care and styling brand in the multi-billion-dollar beauty industry. As part of the transaction, we granted a worldwide license to Drybar Holdings LLC, the owner and long-time operator of Drybar blowout salons, to use the Drybar trademark in their continued operation of Drybar salons. The salons will exclusively use, promote, and sell Drybar products globally. We accounted for the acquisition as a purchase of a business and recorded the excess purchase price as goodwill. We completed our analysis of the economic lives of the assets acquired and determined the appropriate fair values of the acquired assets. We assigned $30.0 million to trade names and are amortizing over a 15 year expected life. We assigned $17.0 million to customer relationships and are amortizing over a 14.5 year expected life. We used historical attrition rates to assign the expected life. We assigned $10.0 million to a consulting agreement and $6.0 million to a non-compete provision, and we are amortizing these assets over expected lives of 5 and 10 years, respectively. The following schedule presents the net assets recorded upon the acquisition of Drybar Products on January 23, 2020: (in thousands) Assets: Receivables $ 7,710 Inventory 16,603 Prepaid expenses and other current assets 190 Property and equipment 1,472 Goodwill 172,933 Trade names - definite 30,000 Other intangible assets - definite 33,000 Subtotal - assets 261,908 Liabilities: Accounts payable 1,948 Accrued expenses 4,099 Subtotal - liabilities 6,047 Net assets recorded $ 255,861 The fair values of the above assets acquired and liabilities assumed were estimated by applying income and market approaches. Key assumptions include various discount rates based upon a 12.6% weighted average cost of capital; royalty rates used in the determination of trade names and customer relationship asset values of 5.0% and 3.0%, respectively; and a customer attrition rate used in the determination of customer relationship values of 6.7% per year.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Nov. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Note 8 - Goodwill and Intangible Assets We perform annual impairment tests each fiscal year during the fourth quarter and interim impairment tests, if and when necessary. For the three and nine month periods ended November 30, 2020 and 2019, we did not record any impairment charges. The following table summarizes the carrying amounts and accumulated amortization for all intangible assets by segment as of the end of the periods presented: November 30, 2020 February 29, 2020 (in thousands) Gross Cumulative Accumulated Net Book Gross Cumulative Accumulated Net Book Housewares: Goodwill $ 282,056 $ — $ — $ 282,056 $ 282,056 $ — $ — $ 282,056 Trademarks - indefinite 134,200 — — 134,200 134,200 — — 134,200 Other intangibles - finite 43,063 — (23,011) 20,052 42,095 — (21,469) 20,626 Subtotal 459,319 — (23,011) 436,308 458,351 — (21,469) 436,882 Health & Home: Goodwill 284,913 — — 284,913 284,913 — — 284,913 Trademarks - indefinite 54,000 — — 54,000 54,000 — — 54,000 Licenses - finite 17,050 — (16,015) 1,035 17,050 — (15,752) 1,298 Licenses - indefinite 7,400 — — 7,400 7,400 — — 7,400 Other intangibles - finite 118,446 — (105,293) 13,153 118,223 — (98,142) 20,081 Subtotal 481,809 — (121,308) 360,501 481,586 — (113,894) 367,692 Beauty: Goodwill 172,932 — — 172,932 244,925 (71,993) — 172,932 Trademarks - finite 30,151 — (1,827) 28,324 33,392 — (3,564) 29,828 Licenses - finite 13,697 — (13,037) 660 13,697 — (12,800) 897 Other intangibles - finite 33,035 — (3,242) 29,793 79,171 — (46,549) 32,622 Subtotal 249,815 — (18,106) 231,709 371,185 (71,993) (62,913) 236,279 Total $ 1,190,943 $ — $ (162,425) $ 1,028,518 $ 1,311,122 $ (71,993) $ (198,276) $ 1,040,853 (1) The cumulative goodwill impairment of approximately $72.0 million in the Beauty segment is related to goodwill associated with the Personal Care business, which was reclassified to assets held for sale. (2) Includes the retirement and reclassification of accumulated amortization of $49.4 million related to assets associated with the Personal Care business, which were reclassified to assets held for sale. The following tables summarize the aggregate amortization expense attributable to intangible assets recorded in SG&A in the condensed consolidated statements of income for the periods shown below, as well as our estimated amortization expense for fiscal 2021 through 2026: (in thousands) Three Months Ended Nine Months Ended November 30, 2020 $ 4,501 $ 13,527 November 30, 2019 4,790 13,129 Estimated Amortization Expense (in thousands) Fiscal 2021 $ 16,751 Fiscal 2022 10,361 Fiscal 2023 10,287 Fiscal 2024 9,902 Fiscal 2025 9,281 Fiscal 2026 7,252

Share-Based Compensation Plans

Share-Based Compensation Plans	9 Months Ended
	Nov. 30, 2020
Share-based Payment Arrangement [Abstract]
Share-Based Compensation Plans	Note 9 - Share-Based Compensation Plans We have equity awards outstanding under several share-based compensation plans. During the three and nine month periods ended November 30, 2020, we had the following share-based compensation activity: • We issued 770 and 2,842 shares to non-employee members of the Board of Directors with a total grant date fair value of $0.1 million and $0.5 million, respectively, and average share prices of $207.98 and $184.56, respectively. • We granted time-vested restricted stock units (“RSUs”) that may be settled for 39 and 2,747 shares of common stock, respectively. The RSUs have a weighted average grant price of $200.00 and $170.69 per share, respectively, for a total award fair value at date of grant of an insignificant amount and $0.5 million, respectively. • We granted time-vested restricted stock awards (“RSAs”) that may vest for 4,171 and 42,143 shares of common stock, respectively. The RSAs have a weighted average grant price of $199.39 and $174.03 per share, respectively, for a total award fair value at date of grant of $0.8 million and $7.3 million, respectively. • There were no grants of performance-based stock units (“PSUs”) during the three months ended November 30, 2020. During the nine months ended November 30, 2020, we granted PSUs that may be settled for 4,970 shares of common stock at target. The PSUs have a weighted average grant price of $170.27 per share, for a total award fair value at date of grant of $0.8 million. • There were no grants of performance-based restricted stock awards (“PSAs”) during the three months ended November 30, 2020. During the nine months ended November 30, 2020, we granted PSAs that may vest for 86,004 shares of common stock at target. The PSAs have a weighted average grant price of $170.27 per share, for a total award fair value at date of grant of $14.6 million. • RSUs for 18,196 and 64,948 shares vested, respectively, with a total fair value at settlement of $3.6 million and $11.3 million, respectively, and average share prices of $195.29 and $173.33, respectively. • RSAs for 605 and 7,929 shares vested, respectively, with a total fair value at settlement of $0.1 million and $1.4 million, respectively, and average share prices of $201.29 and $174.75, respectively. • There were no PSUs that vested and settled during the three months ended November 30, 2020. During the nine months ended November 30, 2020, PSUs for 112,720 shares vested and settled, with a total settlement date fair value of $18.6 million, and an average share price of $164.58. • Employees exercised stock options to purchase 850 shares and 13,540 shares of common stock, respectively. • There were 12,264 and 26,830 purchases of common stock, respectively, under the employee stock purchase plan at an average price of $139.88 and $134.78 per share, respectively. We recorded the following share-based compensation expense in SG&A for the periods shown below: Three Months Ended November 30, Nine Months Ended November 30, (in thousands, except per share data) 2020 2019 2020 2019 Stock options $ 3 $ 21 $ 18 $ 172 Directors stock compensation 161 140 525 421 Performance based and other stock awards 6,084 4,138 19,134 17,366 Employee stock purchase plan 491 459 977 784 Share-based compensation expense 6,739 4,758 20,654 18,743 Less income tax benefits (403) (343) (1,406) (1,434) Share-based compensation expense, net of income tax benefits $ 6,336 $ 4,415 $ 19,248 $ 17,309 Impact of share-based compensation on EPS: Basic $ 0.25 $ 0.18 $ 0.76 $ 0.69 Diluted $ 0.25 $ 0.17 $ 0.76 $ 0.68

Repurchases of Helen of Troy Co

Repurchases of Helen of Troy Common Stock	9 Months Ended
	Nov. 30, 2020
Equity [Abstract]
Repurchase of Helen of Troy Common Stock	Note 10 - Repurchase of Helen of Troy Common Stock In May 2019, we announced that our Board of Directors authorized the repurchase of up to $400 million of our outstanding common stock. The authorization was effective May 8, 2019 for a period of three years and replaced our previous repurchase authorization, of which approximately $107.4 million remained. These repurchases may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. The number of shares purchased and the timing of the purchases will depend on a number of factors, including share price, trading volume and general market conditions, working capital requirements, general business conditions, financial conditions, any applicable contractual limitations, and other factors, including alternative investment opportunities. As of November 30, 2020, our repurchase authorization allowed for the purchase of $190.0 million of common stock. Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the equity holder can be paid for by having the equity holder tender back to the Company a number of shares at fair value equal to the amounts due. Net exercises are treated as purchases and retirements of shares. The following table summarizes our share repurchase activity for the periods shown: Three Months Ended November 30, Nine Months Ended November 30, (in thousands, except share and per share data) 2020 2019 2020 2019 Common stock repurchased on the open market: Number of shares 960,829 — 960,829 — Aggregate value of shares $ 191,606 $ — $ 191,606 $ — Average price per share $ 199.42 $ — $ 199.42 $ — Common stock received in connection with share-based compensation: Number of shares 6,115 6,509 67,740 77,067 Aggregate value of shares $ 1,194 $ 1,002 $ 11,355 $ 10,133 Average price per share $ 195.26 $ 153.88 $ 167.63 $ 131.48

Restructuring Plan

Restructuring Plan	9 Months Ended
	Nov. 30, 2020
Restructuring and Related Activities [Abstract]
Restructuring Plan	Note 11 - Restructuring Plan In October 2017, we announced that we had approved a restructuring plan (referred to as “Project Refuel”) intended to improve the performance primarily in the Beauty and former Nutritional Supplements segments. Project Refuel includes a reduction-in-force and the elimination of certain contracts. We are targeting total annualized profit improvements of approximately $9.0 to $11.0 million over the duration of the plan. We estimate the plan will be completed during the first quarter of fiscal 2022, and expect to incur total restructuring charges of approximately $9.5 million over the duration of the plan. Restructuring provisions are determined based on estimates prepared at the time the restructuring actions are approved by management and are revised periodically. An insignificant change in the estimate of pre-tax restructuring costs was recorded during the three month period ended November 30, 2020. For the nine month period ended November 30, 2020 , we incurred pre-tax restructuring charges of $0.4 million. Since implementing Project Refuel, we have incurred $9.1 million of pre-tax restructuring costs as of November 30, 2020. During the three and nine month periods ended November 30, 2020, we made total cash restructuring payments of $0.2 million and $0.9 million, respectively, compared to $0.3 million and $1.8 million, respectively, for the same periods last year. Since implementing Project Refuel, we have made total cash restructuring payments of $8.9 million. We had a remaining liability of $0.2 million as of November 30, 2020.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Nov. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 12 - Commitments and Contingencies Legal Matters We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.

Long-Term Debt

Long-Term Debt	9 Months Ended
	Nov. 30, 2020
Debt Disclosure [Abstract]
Long-Term Debt	Note 13 - Long-Term Debt Credit Agreement As of February 29, 2020, we had a credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provided for an unsecured total revolving commitment of $1.0 billion. Borrowings accrued interest under one of two alternative methods (based upon a base rate or LIBOR) as described in the Credit Agreement. With each borrowing against our credit line, we could elect the interest rate method based on our funding needs at the time. We also incurred loan commitment and letter of credit fees under the Credit Agreement. On March 13, 2020, we entered into an amendment to the Credit Agreement. The amendment extended the maturity of the commitment under the Credit Agreement from December 7, 2021 to March 13, 2025. Further, the amendment increased the unsecured revolving commitment from $1.0 billion to $1.25 billion. The accordion was amended to increase it from $200 million to $300 million and to include the ability to use it for term loan commitments. The accordion permits the Company to request to increase its borrowing capacity, not to exceed the $300 million commitment in the aggregate, provided certain conditions are met, including lender approval. Any increase to term loan commitments and revolving loan commitments must be made on terms identical to the revolving loans under the Credit Agreement and must have a maturity date of no earlier than March 13, 2025. Following the amendment, borrowings under the Credit Agreement bear interest at either the base rate or LIBOR, plus a margin based on the Net Leverage Ratio (as defined in the Credit Agreement) of 0% to 1.0% and 1.0% to 2.0% for base rate and LIBOR borrowings, respectively. Outstanding letters of credit reduce the borrowing availability under the Credit Agreement on a dollar-for-dollar basis. We are able to repay amounts borrowed at any time without penalty. As of November 30, 2020, the outstanding revolving loan principal balance was $426.0 million (excluding prepaid financing fees) and the balance of outstanding letters of credit was $19.2 million. For the three and nine month periods ended November 30, 2020, borrowings under the Credit Agreement incurred interest expense at rates ranging from 1.14% to 3.25% and 1.14% to 4.75%, respectively. As of November 30, 2020, the amount available for borrowings under the Credit Agreement was $804.8 million. Covenants in the Credit Agreement limit the amount of total indebtedness we can inc ur. As of November 30, 2020, these covenants did not limit our ability to incur $804.8 million of additional debt under the Credit Agreement. Other Debt Agreements As of November 30, 2020, we have an aggregate principal balanc e of $18.6 million (excluding prepaid financing fees) under a loan agreement (the “MBFC Loan”) with the Mississippi Business Finance Corporation (the “MBFC”), which was entered into in connection with the issuance by MBFC of taxable industrial development revenue bonds (the “Bonds”). The borrowings were used to fund construction of our Olive Branch, Mississippi distribution facility. Since March 2018, the MBFC Loan can be called by the holder at any time. The remaining loan balance is payable as follows: $1.9 million annually on March 1, 2021 and 2022; and $14.8 million on March 1, 2023. Any remaining outstanding principal and interest is due upon maturity on March 1, 2023. On May 14, 2020, Helen of Troy Limited and certain of its subsidiaries entered into the Sixth Amendment to Guaranty Agreement (the “Amended Guaranty”) in favor of Bank of America, N.A. The Amended Guaranty amends the Guaranty Agreement (as amended, the “Guaranty Agreement”), dated March 1, 2013, made by the Company and certain of its subsidiaries in favor of Bank of America, N.A. and other lenders. Certain of the representations and warranties, and covenants in the Guaranty Agreement were amended by the Amended Guaranty to include or modify certain baskets, exceptions and other customary provisions. The Bonds were issued under a Trust Indenture, dated as of March 1, 2013 (as supplemented, the “Indenture”), by and between MBFC and U.S. Bank National Association, as trustee (the “Trustee”). On May 14, 2020, MBFC and U.S. Bank National Association, as Trustee, entered into the Fifth Supplemental Trust Indenture, effective May 14, 2020 (the “Fifth Supplemental Indenture”), with the consent of Kaz USA, Inc. (“Kaz USA”) and Bank of America, N.A., the purchaser of the Bonds. The Base Rate (as defined in the Indenture) and Eurodollar Rate (as defined in the Indenture) were each amended. As amended by the Fifth Supplemental Indenture, the Bonds and the related loans to Kaz USA will bear interest at a Base Rate or Eurodollar Rate plus a margin based on the Net Leverage Ratio (as defined in the Fifth Supplemental Indenture). The Fifth Supplemental Indenture amended the pricing grid for the Eurodollar and Base Rate margins. All of our debt is unconditionally guaranteed, on a joint and several basis, by the Company and certain of its subsidiaries. Our debt agreements require the maintenance of certain key financial covenants defined in the accompanying Management's Discussion and Analysis of Financial Condition and Results of Operations - Financial Condition, Liquidity and Capital Resources - Credit and Other Debt Agreements . Our debt agreements also contain other customary covenants, including, among other things, covenants restricting or limiting us, except under certain conditions set forth therein, from (1) incurring debt, (2) incurring liens on our properties, (3) making certain types of investments, (4) selling certain assets or making other fundamental changes relating to mergers and consolidations, and (5) repurchasing shares of our common stock and paying dividends. Our debt agreements also contain customary events of default, including failure to pay principal or interest when due, among others. Our debt agreements are cross-defaulted to each other. Upon an event of default under our debt agreements, the holders or lenders may, among other things, accelerate the maturity of any amounts outstanding under our debt agreements. The commitments of the lenders to make loans to us under the Credit Agreement are several and not joint. Accordingly, if any lender fails to make loans to us, our available liquidity could be reduced by an amount up to the aggregate amount of such lender’s commitments under the Credit Agreement. As of November 30, 2020, we were in compliance with all covenants as defined under the terms of the Credit Agreement and our other debt agreements. A summary of our long-term debt including prepaid financing fees follows: (in thousands) November 30, 2020 February 29, 2020 MBFC Loan (1) $ 18,548 $ 20,451 Credit Agreement (2) 421,833 318,854 Total long-term debt 440,381 339,305 Less current maturities of long-term debt (1,884) (1,884) Long-term debt, excluding current maturities $ 438,497 $ 337,421 (1) The MBFC Loan is unsecured and bears floating interest based on either LIBOR plus a margin of up to 2.0%, or a Base Rate plus a margin of up to 1.0%, as determined by the interest rate elected and the Net Leverage Ratio defined in the Indenture. Since March 2018, the loan may be called by the holder at any time. The loan can be prepaid without penalty. The remaining principal balance is payable as follows: $1.9 million annually on March 1, 2021 and 2022; and $14.8 million on March 1, 2023. Any remaining outstanding principal and interest is due upon maturity on March 1, 2023. (2) The Credit Agreement's floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $225 million of the outstanding principal balance under the Credit Agreement (see Notes 14, 15 and 16 for additional information regarding the interest rate swaps). At November 30, 2020 and February 29, 2020, our long-term debt has floating interest rates, and its book value approximates its fair value.

Fair Value

Fair Value	9 Months Ended
	Nov. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value	Note 14 - Fair Value We classify our various assets and liabilities recorded or reported at fair value under a hierarchy prescribed by GAAP that prioritizes inputs to fair value measurement techniques into three broad levels: Level 1: Observable inputs such as quoted prices for identical assets or liabilities in active markets; Level 2: Observable inputs other than quoted prices that are directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets; quoted prices for similar or identical assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions. Assets and liabilities subject to classification are classified upon acquisition. When circumstances dictate the transfer of an asset or liability to a different level, our policy is to recognize the transfer at the beginning of the reporting period in which the event resulting in the transfer occurred. The following tables present the fair value of our financial assets and liabilities measured on a recurring basis as of the end of the periods shown: Fair Values (1) (in thousands) November 30, 2020 February 29, 2020 Assets: Money market accounts $ 118,559 $ 2,648 Interest rate swaps — — Foreign currency contracts 7 2,083 Total assets $ 118,566 $ 4,731 Liabilities: Floating rate debt $ 440,381 $ 339,305 Interest rate swaps 11,627 10,717 Foreign currency contracts 5,328 159 Total liabilities $ 457,336 $ 350,181 (1) Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable. The carrying amounts of cash and cash equivalents, receivables and accounts payable approximate fair value because of the short maturity of these items. We use derivatives for hedging purposes and our derivatives are primarily interest rate swaps, foreign currency contracts and cross-currency debt swaps. See Notes 13, 15 and 16 to these condensed consolidated financial statements for more information on our hedging activities. We classify our floating rate debt as a Level 2 item because the estimation of the fair market value requires the use of a discount rate based upon current market rates of interest for obligations with comparable remaining terms. Such comparable rates are considered significant other observable market inputs. The book value of the floating rate debt approximates its fair value as of the reporting date. Our other non-financial assets include goodwill, other intangible assets and assets held for sale, which we classify as Level 3 items. These assets are measured at fair value on a non-recurring basis as part of our impairment testing. Note 8 to these condensed consolidated financial statements contains additional information related to goodwill and intangible assets, and our impairment testing.

Financial Instruments and Risk

Financial Instruments and Risk Management	9 Months Ended
	Nov. 30, 2020
Financial Instruments, Owned, at Fair Value [Abstract]
Financial Instruments and Risk Management	Note 15 - Financial Instruments and Risk Management Foreign Currency Risk Our functional currency is the U.S. Dollar. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”). Such transactions include sales, certain inventory purchases and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies. During the three and nine month periods ended November 30, 2020, approximately 11% and 12%, respectively, of our net sales revenue was in foreign currencies, compared to 17% and 14%, respectively, for the same periods last year. These sales were primarily denominated in Euros, British Pounds, Canadian Dollars, and Mexican Pesos. We make most of our inventory purchases from the Far East and primarily use the U.S. Dollar for such purchases. In our condensed consolidated statements of income, exchange gains and losses resulting from the remeasurement of foreign taxes receivable, taxes payable, deferred tax assets, and deferred tax liabilities are recognized in their respective income tax lines, and all other foreign exchange gains and losses are recognized in SG&A. During the three and nine month periods ended November 30, 2020, we recorded net exchange gains from foreign currency fluctuations, including the impact of currency hedges and the cross-currency debt swaps, of $0.4 million and $0.5 million, respectively, in SG&A compared to net foreign exchange gains of $0.6 million and $2.2 million, respectively, for the same periods last year. We hedge against certain foreign currency exchange rate-risk by using a series of forward contracts and zero-cost collars designated as cash flow hedges and mark-to-market derivatives to protect against the foreign currency exchange risk inherent in our forecasted transactions denominated in currencies other than the U.S. Dollar. We do not enter into any forward exchange contracts or similar instruments for trading or other speculative purposes. The effective portion of the changes in fair value of these instruments is reported in Accumulated Other Comprehensive Income (Loss) (“AOCI”) and reclassified into SG&A in the same period they are settled. The ineffective portion, which is not material for any year presented, is immediately recognized in SG&A. Interest Rate Risk Interest on our outstanding debt as of November 30, 2020 is based on floating interest rates. If short-term interest rates increase, we will incur higher interest expense on any future outstanding balances of floating rate debt. Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $225.0 million of the outstanding principal balance under the Credit Agreement, which totaled $426.0 million (excluding prepaid finance fees) as of November 30, 2020. The following table summarizes the fair values of our derivative instruments as of the end of the periods shown: (in thousands) November 30, 2020 Hedge Final Notional Amount Prepaid Other Assets Accrued Other Zero-cost collar - Euro Cash flow 02/2021 € 2,000 $ — $ — $ 15 $ — Foreign currency contracts - sell Euro Cash flow 02/2022 € 46,000 — — 1,758 433 Foreign currency contracts - sell Canadian Dollar Cash flow 02/2022 $ 26,000 — — 763 93 Zero-cost collar - Pound Cash flow 02/2021 £ 2,000 — — 122 — Foreign currency contracts - sell Pound Cash flow 02/2022 £ 23,790 — — 662 266 Foreign currency contracts - sell Mexican Peso Cash flow 02/2021 $ 30,000 7 — — — Interest rate swaps Cash flow 01/2024 $ 225,000 — — 4,986 6,641 Subtotal 7 — 8,306 7,433 Derivatives not designated under hedge accounting Foreign currency contracts - cross-currency debt swaps - Euro (1) 04/2022 € 6,000 — — — 732 Foreign currency contracts - cross-currency debt swaps - Pound (1) 04/2022 £ 4,500 — — — 484 Subtotal — — — 1,216 Total fair value $ 7 $ — $ 8,306 $ 8,649 (in thousands) February 29, 2020 Hedge Type Final Notional Amount Prepaid Other Assets Accrued Other Zero-cost collar - Euro Cash flow 02/2021 € 8,000 $ 74 $ — $ — $ — Foreign currency contracts - sell Euro Cash flow 05/2021 € 25,875 837 — — 15 Foreign currency contracts - sell Canadian Dollar Cash flow 02/2021 $ 14,000 202 — — — Zero-cost collar - Pound Cash flow 02/2021 £ 6,500 — — 144 — Foreign currency contracts - sell Pound Cash flow 05/2021 £ 13,000 435 23 — — Foreign currency contracts - sell Mexican Peso Cash flow 05/2020 $ 10,000 12 — — — Interest rate swaps Cash flow 01/2024 $ 225,000 — — 3,489 7,228 Subtotal 1,560 23 3,633 7,243 Derivatives not designated under hedge accounting Foreign currency contracts - cross-currency debt swaps - Euro (1) 04/2020 € 4,400 473 — — — Foreign currency contracts - cross-currency debt swaps - Pound (1) 04/2020 £ 5,000 27 — — — Subtotal 500 — — — Total fair value $ 2,060 $ 23 $ 3,633 $ 7,243 (1) These are foreign currency contracts for which we have not elected hedge accounting. We refer to them as “cross-currency debt swaps”. They, in effect, adjust the currency denomination of a portion of our outstanding debt to the Euro and British Pound, as applicable, for the notional amounts reported, creating an economic hedge against currency movements. The following table summarizes the pre-tax effect of derivative instruments for the periods shown: Three Months Ended November 30, Gain (Loss) Gain (Loss) Reclassified from Gain (Loss) Recognized (in thousands) 2020 2019 Location 2020 2019 Location 2020 2019 Currency contracts - cash flow hedges $ 1,550 $ (2,739) SG&A $ 549 $ (630) $ — $ — Interest rate swaps - cash flow hedges 1,539 2,084 Interest expense — — Interest expense (1,289) (162) Cross-currency debt swaps - principal — — — — SG&A 23 (389) Cross-currency debt swaps - interest — — — — Interest Expense (2) 73 Total $ 3,089 $ (655) $ 549 $ (630) $ (1,268) $ (478) Nine Months Ended November 30, Gain (Loss) Gain (Loss) Reclassified from Gain (Loss) Recognized (in thousands) 2020 2019 Location 2020 2019 Location 2020 2019 Currency contracts - cash flow hedges $ (5,653) $ (3,407) SG&A $ (124) $ (2,840) $ — $ — Interest rate swaps - cash flow hedges (910) (7,242) Interest expense — — Interest expense (3,222) 69 Cross-currency debt swaps - principal — — — — SG&A (1,075) 419 Cross-currency debt swaps - interest — — — — Interest expense 72 147 Total $ (6,563) $ (10,649) $ (124) $ (2,840) $ (4,225) $ 635 We expect pre-tax losses of $8.3 million associated with foreign currency contracts and interest rate swaps currently reported in accumulated other comprehensive income, to be reclassified into income over the next twelve months. The amount ultimately realized, however, will differ as exchange rates vary and the underlying contracts settle. Counterparty Credit Risk Financial instruments, including foreign currency contracts and cross-currency debt swaps, expose us to counterparty credit risk for non-performance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments. Although our theoretical credit risk is the replacement cost at the then-estimated fair value of these instruments, we believe that the risk of incurring credit losses is remote.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	9 Months Ended
	Nov. 30, 2020
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Accumulated Other Comprehensive Income (Loss)	Note 16 - Accumulated Other Comprehensive Income (Loss) The following table summarizes changes in AOCI by component and related tax effects for the periods shown: (in thousands) Interest Foreign Total Balance at February 29, 2020 $ (8,199) $ 1,194 $ (7,005) Other comprehensive loss before reclassification (910) (5,653) (6,563) Amounts reclassified out of AOCI — 124 124 Tax effects 214 945 1,159 Other comprehensive loss (696) (4,584) (5,280) Balance at November 30, 2020 $ (8,895) $ (3,390) $ (12,285) Balance at February 28, 2019 $ 132 $ 1,059 $ 1,191 Other comprehensive loss before reclassification (7,242) (3,407) (10,649) Amounts reclassified out of AOCI — 2,840 2,840 Tax effects 1,680 53 1,733 Other comprehensive loss (5,562) (514) (6,076) Balance at November 30, 2019 $ (5,430) $ 545 $ (4,885)

Segment Information

Segment Information	9 Months Ended
	Nov. 30, 2020
Segment Reporting [Abstract]
Segment Information	Note 17 - Segment Information The following tables present segment information for the periods shown: Three Months Ended November 30, 2020 (in thousands) Housewares Health & Home Beauty (1) Total Sales revenue, net $ 222,400 $ 250,158 $ 165,179 $ 637,737 Restructuring charges (12) — — (12) Operating income 37,658 30,478 32,573 100,709 Capital and intangible asset expenditures 1,375 2,441 370 4,186 Depreciation and amortization 2,371 4,106 3,042 9,519 Three Months Ended November 30, 2019 (in thousands) Housewares Health & Home Beauty Total Sales revenue, net $ 183,211 $ 185,810 $ 105,716 $ 474,737 Restructuring charges — — 12 12 Operating income 42,272 24,372 12,625 79,269 Capital and intangible asset expenditures 2,272 1,917 197 4,386 Depreciation and amortization 2,263 3,740 2,757 8,760 Nine Months Ended November 30, 2020 (in thousands) Housewares Health & Home Beauty (1) Total Sales revenue, net $ 564,891 $ 661,568 $ 362,965 $ 1,589,424 Restructuring charges 251 — 104 355 Operating income 106,294 95,782 54,887 256,963 Capital and intangible asset expenditures 6,912 10,346 2,165 19,423 Depreciation and amortization 6,743 12,331 8,921 27,995 Nine Months Ended November 30, 2019 (in thousands) Housewares Health & Home Beauty Total Sales revenue, net $ 496,017 $ 499,543 $ 269,507 $ 1,265,067 Restructuring charges 90 — 971 1,061 Operating income 109,170 51,836 19,990 180,996 Capital and intangible asset expenditures 8,354 4,115 778 13,247 Depreciation and amortization 5,292 12,322 7,262 24,876 (1) The three and nine month periods ended November 30, 2020 include three and nine months of operating results for Drybar Products, respectively, which was acquired on January 23, 2020, with no comparable results in the same periods last year. For additional information regarding the Drybar Products acquisition, see Note 7 to the accompanying condensed consolidated financial statements. We compute segment operating income based on net sales revenue, less cost of goods sold, SG&A, restructuring charges, and any asset impairment charges associated with the segment. The SG&A used to compute each segment’s operating income is directly associated with the segment, plus shared service and corporate overhead expenses that are allocable to the segment. We do not allocate non-operating income and expense, including interest or income taxes, to operating segments.

Income Taxes

Income Taxes	9 Months Ended
	Nov. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Note 18 - Income Taxes The period-over-period comparison of our effective tax rate is often impacted by the mix of taxable income in our various tax jurisdictions. Due to our organization in Bermuda and the ownership structure of our foreign subsidiaries, many of which are not owned directly or indirectly by a U.S. parent company, an immaterial amount of our foreign income is subject to U.S. taxation on a permanent basis under current law. Additionally, our intellectual property is largely owned by our foreign subsidiaries, resulting in proportionally higher earnings in jurisdictions with lower statutory tax rates, which decreases our overall effective tax rate. The taxable income earned in each jurisdiction, whether U.S. or foreign, is determined by the subsidiary's operating results, transfer pricing and tax regulations in the related jurisdictions. For interim periods, our income tax expense and resulting effective tax rate are based upon an estimated annual effective tax rate adjusted for the effects of items required to be treated as discrete to the period, including changes in tax laws, changes in estimated exposures for uncertain tax positions and other items. For the three months ended November 30, 2020, income tax expense as a percentage of income before income tax was 14.0% compared to 10.3% for the same period last year. The year-over-year increase in the effective tax rate is primarily due to an increase in liabilities related to uncertain tax positions. On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (“CARES”) Act was enacted and signed into law. The CARES Act is an emergency economic stimulus package in response to the COVID-19 outbreak that contains numerous tax provisions. Among other things, the CARES Act included technical corrections to the effective date language in the Tax Cuts and Jobs Act (the “Tax Act”) related to net operating loss carrybacks. Upon the enactment of the Tax Act in fiscal 2018, there was a net operating loss on our balance sheet, which was measured using the U.S. statutory tax rate in effect prior to enactment. As a result of the Tax Act, we were required to record a one-time charge of $17.9 million in fiscal 2018, which included a charge of $9.4 million to remeasure the net operating loss at the reduced rate at which it was expected to reverse in the future. The CARES Act effectively reversed the impact of the Tax Act on our net operating loss, resulting in a corresponding tax benefit of $9.4 million recorded in the first quarter of fiscal 2021. For the nine months ended November 30, 2020, income tax expense as a percentage of income before income tax was 6.5% compared to income tax expense of 9.6% for the same period last year, primarily due to this benefit. Income tax expense for the nine months ended November 30, 2020 also includes other discrete benefits to include reductions of U.S. BEAT tax (Base Erosion and Anti-Abuse) and GILTI tax (Global Intangible Low-Tax Income), the recognition of excess tax benefits from share-based compensation settlements, and one-time benefits related to the transition of our Macau entity from offshore to onshore status, partially offset by increases in liabilities related to uncertain tax positions. During fiscal 2017, we received an assessment from a state tax authority which adjusted taxable income applicable to the particular state resulting from interpretations of certain state income tax provisions applicable to our legal structure. During the time the dispute was ongoing, we believe we accurately reported our taxable income and vigorously protested the assessment through administrative processes with the state. During the quarter, we reached an agreement in principle to settle the $6.0 million assessment in dispute for $0.5 million. The agreement was signed on December 4, 2020. Our Macau subsidiary generates income from the sale of the goods that it has sourced and procured. This subsidiary is responsible for the sourcing and procurement of a large portion of the products that we sell. We currently have an indefinite tax holiday in Macau conditioned on the subsidiary meeting certain employment and investment thresholds. The Macau Offshore Law and its supplementary regulations that grant tax incentives to approved offshore institutions will be abolished on January 1, 2021. Existing approved offshore institutions such as ours can continue to operate under the offshore regime until the end of the calendar year 2020. Beginning in calendar year 2021, our Macau subsidiary will transition to onshore status and become subject to a statutory corporate income tax of approximately 12%. We expect the impact of this change to increase our overall effective tax rate by 1.5 to 2.0 percentage points on an annual basis, beginning with our fiscal 2022. Because our Macau subsidiary is not directly or indirectly owned by a U.S. parent, there is no U.S. tax liability associated with the income generated in Macau.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Nov. 30, 2020
Earnings Per Share [Abstract]
Earnings Per Share	Note 19 - Earnings Per Share We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period. We compute diluted earnings per share using the weighted average number of shares of common stock outstanding plus the effect of dilutive securities. Dilutive securities at any given point in time may consist of outstanding options to purchase common stock and issued and contingently issuable unvested RSUs, PSUs, RSAs, PSAs and other stock based awards. Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method. See Note 9 to these condensed consolidated financial statements for more information regarding stock-based awards. The following table presents our weighted average basic and diluted shares for the periods shown: Three Months Ended Nine Months Ended (in thousands) 2020 2019 2020 2019 Weighted average shares outstanding, basic 24,965 25,161 25,182 25,099 Incremental shares from share-based compensation arrangements 227 235 168 196 Weighted average shares outstanding, diluted 25,192 25,396 25,350 25,295 Anti-dilutive securities 4 134 149 217

Subsequent Events

Subsequent Events	9 Months Ended
	Nov. 30, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 20 - Subsequent Events On December 22, 2020, we entered into an amended and extended Trademark License Agreement with Revlon to license Revlon’s trademark for hair care appliances and tools (the “Revlon License”). The Revlon License grants us an exclusive, global, fully paid-up license to use the licensed trademark to manufacture, sell and distribute licensed merchandise in accordance with the terms of the agreement. The Revlon License has an initial term of 40 years, which will automatically renew at the end of the initial term for three consecutive additional 20-year periods unless we give notice of non-renewal. The Revlon License amends and restates the existing Revlon trademark licensing agreements entirely, and eliminates ongoing royalties we have historically paid and recognized as expense within SG&A in accordance with such agreements. In exchange for this exclusive global license, we paid a one-time, up-front license fee of $72.5 million, which will be recorded as an intangible asset at cost and amortized on a straight-line basis over a useful life of 40 years, representing the initial term. As a result of the Revlon License, we are no longer obligated to pay royalties to Revlon, and thus will not recognize royalty expense after December 22, 2020, the effective date of the Revlon License.

Basis of Presentation and Rel_2

Basis of Presentation and Related Information (Policies)	9 Months Ended
	Nov. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Presentation of financial statements	Our condensed consolidated financial statements are prepared in U.S. Dollars. All intercompany accounts and transactions are eliminated in consolidation. The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. The severity, duration and the economic consequences of COVID-19 are uncertain, evolving and difficult to predict. Therefore, our estimates and assumptions may change materially in future periods in response to COVID-19. Actual results may differ materially from those estimates.
Reclassification	We have reclassified, combined or separately disclosed certain amounts in the prior years’ condensed consolidated financial statements and accompanying footnotes to conform with the current period’s presentation.
New accounting pronouncements	Not Yet Adopted In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which provides for certain updates to reduce complexity in accounting for income taxes, including the utilization of the incremental approach for intra-period tax allocation, among others. The amendments in ASU 2019-12 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, and will be effective for us in the first quarter of fiscal 2022. We are currently evaluating the impact this guidance may have on our consolidated financial statements. Adopted In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting and other transactions affected by reference rate reform to ease the financial reporting burdens related to the expected market transition from the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates to alternative reference rates. This ASU was effective upon issuance, on March 12, 2020, and may be applied through December 31, 2022. The adoption of this ASU did not have a material impact on our consolidated financial statements. In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (with subsequent targeted amendments), which modifies the measurements of expected credit losses for certain financial instruments and financial assets, including trade receivables. This ASU was effective for us in the first quarter of fiscal 2021, and the adoption of this ASU did not have a material impact on our consolidated financial statements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement . ASU 2018-13 removes certain disclosures, modifies certain disclosures and adds additional disclosures. Certain disclosures in ASU 2018-13 would need to be applied on a retrospective basis and others on a prospective basis. This ASU was effective for us in the first quarter of fiscal 2021, and the adoption of this ASU did not have a material impact on our consolidated financial statements. In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract . ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This ASU was effective for us in the first quarter of fiscal 2021, and the adoption of this ASU did not have a material impact on our consolidated financial statements.

Leases (Tables)

Leases (Tables)	9 Months Ended
	Nov. 30, 2020
Leases [Abstract]
Summary of supplemental lease information	A summary of supplemental lease information is as follows: November 30, 2020 Weighted average remaining lease term ( years ) 10.0 Weighted average discount rate 6.10% Year-to-date cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases (in thousands) $ 4,998
Schedule of estimated lease payments, imputed interest and liabilities	A summary of our estimated lease payments, imputed interest and liabilities as of November 30, 2020 are as follows: (in thousands) Fiscal 2021 (balance for remainder of fiscal year) $ 1,826 Fiscal 2022 7,128 Fiscal 2023 6,123 Fiscal 2024 5,332 Fiscal 2025 5,762 Thereafter 34,370 Total future lease payments 60,541 Less: imputed interest (16,492) Present value of lease liability $ 44,049
Schedule of lease liabilities	November 30, 2020 Lease liabilities, current (1) $ 4,770 Lease liabilities, non-current 39,279 Total lease liability $ 44,049

Assets Held for Sale (Tables)

Assets Held for Sale (Tables)	9 Months Ended
	Nov. 30, 2020
Property, Plant and Equipment [Abstract]
Carrying amounts of major asset classes for Personal Care classified as held-for-sale	The carrying amounts of the major classes of assets for Personal Care that were classified as held for sale are as follows: (in thousands) November 30, 2020 February 29, 2020 Assets: Inventory $ 11,650 $ 17,150 Property and equipment, net of accumulated depreciation of $403 83 83 Goodwill, net of cumulative impairments of $71,993 9,849 9,849 Other intangible assets, net of accumulated amortization of $4,474 17,724 17,724 Total assets held for sale $ 39,306 $ 44,806

Supplemental Balance Sheet In_2

Supplemental Balance Sheet Information (Tables)	9 Months Ended
	Nov. 30, 2020
Balance Sheet Related Disclosures [Abstract]
Schedule of property and equipment	PROPERTY AND EQUIPMENT (in thousands) Estimated November 30, 2020 February 29, 2020 Land - $ 12,644 $ 12,644 Building and improvements 3 - 40 117,061 115,592 Computer, software, furniture and other equipment 3 - 15 98,382 89,257 Tools, molds and other production equipment 3 - 7 43,001 37,652 Construction in progress - 9,169 9,302 Property and equipment, gross 280,257 264,447 Less accumulated depreciation (144,462) (132,340) Property and equipment, net $ 135,795 $ 132,107
Schedule of accrued expenses and other current liabilities	ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (in thousands) November 30, 2020 February 29, 2020 Accrued compensation, benefits and payroll taxes $ 54,667 $ 49,624 Accrued sales discounts and allowances 55,832 34,176 Accrued sales returns 31,919 22,972 Accrued advertising 60,549 31,351 Other 86,601 45,034 Total accrued expenses and other current liabilities $ 289,568 $ 183,157

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
	Nov. 30, 2020
Business Combinations [Abstract]
Schedule of net assets recorded upon the acquisition of business	The following schedule presents the net assets recorded upon the acquisition of Drybar Products on January 23, 2020: (in thousands) Assets: Receivables $ 7,710 Inventory 16,603 Prepaid expenses and other current assets 190 Property and equipment 1,472 Goodwill 172,933 Trade names - definite 30,000 Other intangible assets - definite 33,000 Subtotal - assets 261,908 Liabilities: Accounts payable 1,948 Accrued expenses 4,099 Subtotal - liabilities 6,047 Net assets recorded $ 255,861

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Nov. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of carrying amounts and associated accumulated amortization for all intangible assets by operating segment	The following table summarizes the carrying amounts and accumulated amortization for all intangible assets by segment as of the end of the periods presented: November 30, 2020 February 29, 2020 (in thousands) Gross Cumulative Accumulated Net Book Gross Cumulative Accumulated Net Book Housewares: Goodwill $ 282,056 $ — $ — $ 282,056 $ 282,056 $ — $ — $ 282,056 Trademarks - indefinite 134,200 — — 134,200 134,200 — — 134,200 Other intangibles - finite 43,063 — (23,011) 20,052 42,095 — (21,469) 20,626 Subtotal 459,319 — (23,011) 436,308 458,351 — (21,469) 436,882 Health & Home: Goodwill 284,913 — — 284,913 284,913 — — 284,913 Trademarks - indefinite 54,000 — — 54,000 54,000 — — 54,000 Licenses - finite 17,050 — (16,015) 1,035 17,050 — (15,752) 1,298 Licenses - indefinite 7,400 — — 7,400 7,400 — — 7,400 Other intangibles - finite 118,446 — (105,293) 13,153 118,223 — (98,142) 20,081 Subtotal 481,809 — (121,308) 360,501 481,586 — (113,894) 367,692 Beauty: Goodwill 172,932 — — 172,932 244,925 (71,993) — 172,932 Trademarks - finite 30,151 — (1,827) 28,324 33,392 — (3,564) 29,828 Licenses - finite 13,697 — (13,037) 660 13,697 — (12,800) 897 Other intangibles - finite 33,035 — (3,242) 29,793 79,171 — (46,549) 32,622 Subtotal 249,815 — (18,106) 231,709 371,185 (71,993) (62,913) 236,279 Total $ 1,190,943 $ — $ (162,425) $ 1,028,518 $ 1,311,122 $ (71,993) $ (198,276) $ 1,040,853 (1) The cumulative goodwill impairment of approximately $72.0 million in the Beauty segment is related to goodwill associated with the Personal Care business, which was reclassified to assets held for sale. (2) Includes the retirement and reclassification of accumulated amortization of $49.4 million related to assets associated with the Personal Care business, which were reclassified to assets held for sale.
Summary of amortization expense attributable to intangible assets	The following tables summarize the aggregate amortization expense attributable to intangible assets recorded in SG&A in the condensed consolidated statements of income for the periods shown below, as well as our estimated amortization expense for fiscal 2021 through 2026: (in thousands) Three Months Ended Nine Months Ended November 30, 2020 $ 4,501 $ 13,527 November 30, 2019 4,790 13,129
Schedule of estimated amortization expense of intangible assets	Estimated Amortization Expense (in thousands) Fiscal 2021 $ 16,751 Fiscal 2022 10,361 Fiscal 2023 10,287 Fiscal 2024 9,902 Fiscal 2025 9,281 Fiscal 2026 7,252

Share-Based Compensation Plans

Share-Based Compensation Plans (Tables)	9 Months Ended
	Nov. 30, 2020
Share-based Payment Arrangement [Abstract]
Share-based compensation expense in SG&A	We recorded the following share-based compensation expense in SG&A for the periods shown below: Three Months Ended November 30, Nine Months Ended November 30, (in thousands, except per share data) 2020 2019 2020 2019 Stock options $ 3 $ 21 $ 18 $ 172 Directors stock compensation 161 140 525 421 Performance based and other stock awards 6,084 4,138 19,134 17,366 Employee stock purchase plan 491 459 977 784 Share-based compensation expense 6,739 4,758 20,654 18,743 Less income tax benefits (403) (343) (1,406) (1,434) Share-based compensation expense, net of income tax benefits $ 6,336 $ 4,415 $ 19,248 $ 17,309 Impact of share-based compensation on EPS: Basic $ 0.25 $ 0.18 $ 0.76 $ 0.69 Diluted $ 0.25 $ 0.17 $ 0.76 $ 0.68

Repurchase of Helen of Troy Com

Repurchase of Helen of Troy Common Stock (Tables)	9 Months Ended
	Nov. 30, 2020
Equity [Abstract]
Summary of share repurchase activity	The following table summarizes our share repurchase activity for the periods shown: Three Months Ended November 30, Nine Months Ended November 30, (in thousands, except share and per share data) 2020 2019 2020 2019 Common stock repurchased on the open market: Number of shares 960,829 — 960,829 — Aggregate value of shares $ 191,606 $ — $ 191,606 $ — Average price per share $ 199.42 $ — $ 199.42 $ — Common stock received in connection with share-based compensation: Number of shares 6,115 6,509 67,740 77,067 Aggregate value of shares $ 1,194 $ 1,002 $ 11,355 $ 10,133 Average price per share $ 195.26 $ 153.88 $ 167.63 $ 131.48

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Nov. 30, 2020
Debt Disclosure [Abstract]
Summary of long-term debt	A summary of our long-term debt including prepaid financing fees follows: (in thousands) November 30, 2020 February 29, 2020 MBFC Loan (1) $ 18,548 $ 20,451 Credit Agreement (2) 421,833 318,854 Total long-term debt 440,381 339,305 Less current maturities of long-term debt (1,884) (1,884) Long-term debt, excluding current maturities $ 438,497 $ 337,421 (1) The MBFC Loan is unsecured and bears floating interest based on either LIBOR plus a margin of up to 2.0%, or a Base Rate plus a margin of up to 1.0%, as determined by the interest rate elected and the Net Leverage Ratio defined in the Indenture. Since March 2018, the loan may be called by the holder at any time. The loan can be prepaid without penalty. The remaining principal balance is payable as follows: $1.9 million annually on March 1, 2021 and 2022; and $14.8 million on March 1, 2023. Any remaining outstanding principal and interest is due upon maturity on March 1, 2023. (2) The Credit Agreement's floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $225 million of the outstanding principal balance under the Credit Agreement (see Notes 14, 15 and 16 for additional information regarding the interest rate swaps).

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
	Nov. 30, 2020
Fair Value Disclosures [Abstract]
Schedule of fair value hierarchy of financial assets and liabilities presented at fair value and measured on a recurring basis	The following tables present the fair value of our financial assets and liabilities measured on a recurring basis as of the end of the periods shown: Fair Values (1) (in thousands) November 30, 2020 February 29, 2020 Assets: Money market accounts $ 118,559 $ 2,648 Interest rate swaps — — Foreign currency contracts 7 2,083 Total assets $ 118,566 $ 4,731 Liabilities: Floating rate debt $ 440,381 $ 339,305 Interest rate swaps 11,627 10,717 Foreign currency contracts 5,328 159 Total liabilities $ 457,336 $ 350,181 (1) Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable.

Financial Instruments and Ris_2

Financial Instruments and Risk Management (Tables)	9 Months Ended
	Nov. 30, 2020
Financial Instruments, Owned, at Fair Value [Abstract]
Schedule of fair values of derivative instruments	The following table summarizes the fair values of our derivative instruments as of the end of the periods shown: (in thousands) November 30, 2020 Hedge Final Notional Amount Prepaid Other Assets Accrued Other Zero-cost collar - Euro Cash flow 02/2021 € 2,000 $ — $ — $ 15 $ — Foreign currency contracts - sell Euro Cash flow 02/2022 € 46,000 — — 1,758 433 Foreign currency contracts - sell Canadian Dollar Cash flow 02/2022 $ 26,000 — — 763 93 Zero-cost collar - Pound Cash flow 02/2021 £ 2,000 — — 122 — Foreign currency contracts - sell Pound Cash flow 02/2022 £ 23,790 — — 662 266 Foreign currency contracts - sell Mexican Peso Cash flow 02/2021 $ 30,000 7 — — — Interest rate swaps Cash flow 01/2024 $ 225,000 — — 4,986 6,641 Subtotal 7 — 8,306 7,433 Derivatives not designated under hedge accounting Foreign currency contracts - cross-currency debt swaps - Euro (1) 04/2022 € 6,000 — — — 732 Foreign currency contracts - cross-currency debt swaps - Pound (1) 04/2022 £ 4,500 — — — 484 Subtotal — — — 1,216 Total fair value $ 7 $ — $ 8,306 $ 8,649 (in thousands) February 29, 2020 Hedge Type Final Notional Amount Prepaid Other Assets Accrued Other Zero-cost collar - Euro Cash flow 02/2021 € 8,000 $ 74 $ — $ — $ — Foreign currency contracts - sell Euro Cash flow 05/2021 € 25,875 837 — — 15 Foreign currency contracts - sell Canadian Dollar Cash flow 02/2021 $ 14,000 202 — — — Zero-cost collar - Pound Cash flow 02/2021 £ 6,500 — — 144 — Foreign currency contracts - sell Pound Cash flow 05/2021 £ 13,000 435 23 — — Foreign currency contracts - sell Mexican Peso Cash flow 05/2020 $ 10,000 12 — — — Interest rate swaps Cash flow 01/2024 $ 225,000 — — 3,489 7,228 Subtotal 1,560 23 3,633 7,243 Derivatives not designated under hedge accounting Foreign currency contracts - cross-currency debt swaps - Euro (1) 04/2020 € 4,400 473 — — — Foreign currency contracts - cross-currency debt swaps - Pound (1) 04/2020 £ 5,000 27 — — — Subtotal 500 — — — Total fair value $ 2,060 $ 23 $ 3,633 $ 7,243 (1) These are foreign currency contracts for which we have not elected hedge accounting. We refer to them as “cross-currency debt swaps”. They, in effect, adjust the currency denomination of a portion of our outstanding debt to the Euro and British Pound, as applicable, for the notional amounts reported, creating an economic hedge against currency movements.
Schedule of pre-tax effect of derivative instruments	The following table summarizes the pre-tax effect of derivative instruments for the periods shown: Three Months Ended November 30, Gain (Loss) Gain (Loss) Reclassified from Gain (Loss) Recognized (in thousands) 2020 2019 Location 2020 2019 Location 2020 2019 Currency contracts - cash flow hedges $ 1,550 $ (2,739) SG&A $ 549 $ (630) $ — $ — Interest rate swaps - cash flow hedges 1,539 2,084 Interest expense — — Interest expense (1,289) (162) Cross-currency debt swaps - principal — — — — SG&A 23 (389) Cross-currency debt swaps - interest — — — — Interest Expense (2) 73 Total $ 3,089 $ (655) $ 549 $ (630) $ (1,268) $ (478) Nine Months Ended November 30, Gain (Loss) Gain (Loss) Reclassified from Gain (Loss) Recognized (in thousands) 2020 2019 Location 2020 2019 Location 2020 2019 Currency contracts - cash flow hedges $ (5,653) $ (3,407) SG&A $ (124) $ (2,840) $ — $ — Interest rate swaps - cash flow hedges (910) (7,242) Interest expense — — Interest expense (3,222) 69 Cross-currency debt swaps - principal — — — — SG&A (1,075) 419 Cross-currency debt swaps - interest — — — — Interest expense 72 147 Total $ (6,563) $ (10,649) $ (124) $ (2,840) $ (4,225) $ 635

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	9 Months Ended
	Nov. 30, 2020
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Summary of changes in accumulated other comprehensive income (loss)	The following table summarizes changes in AOCI by component and related tax effects for the periods shown: (in thousands) Interest Foreign Total Balance at February 29, 2020 $ (8,199) $ 1,194 $ (7,005) Other comprehensive loss before reclassification (910) (5,653) (6,563) Amounts reclassified out of AOCI — 124 124 Tax effects 214 945 1,159 Other comprehensive loss (696) (4,584) (5,280) Balance at November 30, 2020 $ (8,895) $ (3,390) $ (12,285) Balance at February 28, 2019 $ 132 $ 1,059 $ 1,191 Other comprehensive loss before reclassification (7,242) (3,407) (10,649) Amounts reclassified out of AOCI — 2,840 2,840 Tax effects 1,680 53 1,733 Other comprehensive loss (5,562) (514) (6,076) Balance at November 30, 2019 $ (5,430) $ 545 $ (4,885)

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Nov. 30, 2020
Segment Reporting [Abstract]
Schedule of segment information	The following tables present segment information for the periods shown: Three Months Ended November 30, 2020 (in thousands) Housewares Health & Home Beauty (1) Total Sales revenue, net $ 222,400 $ 250,158 $ 165,179 $ 637,737 Restructuring charges (12) — — (12) Operating income 37,658 30,478 32,573 100,709 Capital and intangible asset expenditures 1,375 2,441 370 4,186 Depreciation and amortization 2,371 4,106 3,042 9,519 Three Months Ended November 30, 2019 (in thousands) Housewares Health & Home Beauty Total Sales revenue, net $ 183,211 $ 185,810 $ 105,716 $ 474,737 Restructuring charges — — 12 12 Operating income 42,272 24,372 12,625 79,269 Capital and intangible asset expenditures 2,272 1,917 197 4,386 Depreciation and amortization 2,263 3,740 2,757 8,760 Nine Months Ended November 30, 2020 (in thousands) Housewares Health & Home Beauty (1) Total Sales revenue, net $ 564,891 $ 661,568 $ 362,965 $ 1,589,424 Restructuring charges 251 — 104 355 Operating income 106,294 95,782 54,887 256,963 Capital and intangible asset expenditures 6,912 10,346 2,165 19,423 Depreciation and amortization 6,743 12,331 8,921 27,995 Nine Months Ended November 30, 2019 (in thousands) Housewares Health & Home Beauty Total Sales revenue, net $ 496,017 $ 499,543 $ 269,507 $ 1,265,067 Restructuring charges 90 — 971 1,061 Operating income 109,170 51,836 19,990 180,996 Capital and intangible asset expenditures 8,354 4,115 778 13,247 Depreciation and amortization 5,292 12,322 7,262 24,876 (1) The three and nine month periods ended November 30, 2020 include three and nine months of operating results for Drybar Products, respectively, which was acquired on January 23, 2020, with no comparable results in the same periods last year. For additional information regarding the Drybar Products acquisition, see Note 7 to the accompanying condensed consolidated financial statements.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Nov. 30, 2020
Earnings Per Share [Abstract]
Schedule of components of basic and diluted shares	The following table presents our weighted average basic and diluted shares for the periods shown: Three Months Ended Nine Months Ended (in thousands) 2020 2019 2020 2019 Weighted average shares outstanding, basic 24,965 25,161 25,182 25,099 Incremental shares from share-based compensation arrangements 227 235 168 196 Weighted average shares outstanding, diluted 25,192 25,396 25,350 25,295 Anti-dilutive securities 4 134 149 217

Basis of Presentation and Rel_3

Basis of Presentation and Related Information (Details) $ / shares in Units, $ in Millions	Jan. 23, 2020USD ($)	Nov. 30, 2020Segment$ / shares	Feb. 29, 2020$ / shares
Business Combination, Separately Recognized Transactions [Line Items]
Common shares, par value (in dollars per share) | $ / shares		$ 0.10	$ 0.10
Number of segments | Segment		3
Drybar Products LLC
Business Combination, Separately Recognized Transactions [Line Items]
Payment to acquire business | $	$ 255.9

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019	Feb. 29, 2020	Mar. 01, 2019
Lessee, Lease, Description [Line Items]
Operating lease assets	$ (32,277)		$ (32,277)		$ (32,645)
Present value of lease liability	44,049		44,049			$ 47,223
Operating lease expense	1,800	$ 1,500	5,000	$ 4,800
Renal expense associated with operating leases	$ 2,400	$ 2,100	$ 6,600	$ 5,800
Accounting Standards Update 2016-02
Lessee, Lease, Description [Line Items]
Operating lease assets						(37,100)
Present value of lease liability						$ 47,200
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease term of operating issues	1 year		1 year
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease term of operating issues	12 years		12 years

Leases - Additional Lease Infor

Leases - Additional Lease Information (Details) $ in Thousands	9 Months Ended
	Nov. 30, 2020USD ($)
Leases [Abstract]
Weighted average remaining lease term (years)	10 years
Weighted average discount rate (as a percent)	6.10%
Year-to-date cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases (in thousands)	$ 4,998

Leases - Schedule of Operating

Leases - Schedule of Operating Lease Maturities (Details) - USD ($) $ in Thousands	Nov. 30, 2020	Mar. 01, 2019
Leases [Abstract]
Fiscal 2021 (balance for remainder of fiscal year)	$ 1,826
Fiscal 2022	7,128
Fiscal 2023	6,123
Fiscal 2024	5,332
Fiscal 2025	5,762
Thereafter	34,370
Total future lease payments	60,541
Less: imputed interest	(16,492)
Present value of lease liability	$ 44,049	$ 47,223

Leases - Schedule of Lease Liab

Leases - Schedule of Lease Liabilities (Details) - USD ($) $ in Thousands	Nov. 30, 2020	Feb. 29, 2020	Mar. 01, 2019
Leases [Abstract]
Lease liabilities, current	$ 4,770
Lease liabilities, non-current	39,279	$ 40,861
Total lease liability	$ 44,049		$ 47,223

Assets Held for Sale (Details)

Assets Held for Sale (Details) - USD ($) $ in Thousands	Nov. 30, 2020	Feb. 29, 2020
Long Lived Assets Held-for-sale [Line Items]
Assets held for sale	$ 39,306	$ 44,806
Property and equipment, accumulated depreciation	144,462	132,340
Goodwill accumulated impairment	0	71,993
Other intangible assets, accumulated amortization	162,425	148,891
Other Intangible Assets, Held-For-Sale
Long Lived Assets Held-for-sale [Line Items]
Goodwill accumulated impairment	71,993	71,993
Other intangible assets, accumulated amortization	4,474	4,474
Property, Plant and Equipment, Held-for-Sale
Long Lived Assets Held-for-sale [Line Items]
Property and equipment, accumulated depreciation	403	403
Inventory
Long Lived Assets Held-for-sale [Line Items]
Assets held for sale	11,650	17,150
Property and equipment, net of accumulated depreciation of $403
Long Lived Assets Held-for-sale [Line Items]
Assets held for sale	83	83
Goodwill, net of cumulative impairments of $71,993
Long Lived Assets Held-for-sale [Line Items]
Assets held for sale	9,849	9,849
Other intangible assets, net of accumulated amortization of $4,474
Long Lived Assets Held-for-sale [Line Items]
Assets held for sale	$ 17,724	$ 17,724

Supplemental Balance Sheet In_3

Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Nov. 30, 2020	Feb. 29, 2020
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 280,257	$ 264,447
Less accumulated depreciation	(144,462)	(132,340)
Property and equipment, net	135,795	132,107
Land
PROPERTY AND EQUIPMENT
Property and equipment, gross	12,644	12,644
Building and improvements
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 117,061	115,592
Building and improvements | Minimum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	3 years
Building and improvements | Maximum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	40 years
Computer, software, furniture and other equipment
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 98,382	89,257
Computer, software, furniture and other equipment | Minimum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	3 years
Computer, software, furniture and other equipment | Maximum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	15 years
Tools, molds and other production equipment
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 43,001	37,652
Tools, molds and other production equipment | Minimum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	3 years
Tools, molds and other production equipment | Maximum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	7 years
Construction in progress
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 9,169	$ 9,302

Supplemental Balance Sheet In_4

Supplemental Balance Sheet Information - Liabilities (Details) - USD ($) $ in Thousands	Nov. 30, 2020	Feb. 29, 2020
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued compensation, benefits and payroll taxes	$ 54,667	$ 49,624
Accrued sales discounts and allowances	55,832	34,176
Accrued sales returns	31,919	22,972
Accrued advertising	60,549	31,351
Other	86,601	45,034
Total accrued expenses and other current liabilities	$ 289,568	$ 183,157

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) - Drybar Products LLC - USD ($) $ in Millions	Jan. 23, 2020	Feb. 29, 2020
Business Combination, Separately Recognized Transactions [Line Items]
Payment to acquire business	$ 255.9
Acquisition related expenses		$ 2.5
Weighted average cost of capital
Business Combination, Separately Recognized Transactions [Line Items]
Measurement inputs	12.60%
Customer attrition rate
Business Combination, Separately Recognized Transactions [Line Items]
Measurement inputs	6.70%
Trade Names
Business Combination, Separately Recognized Transactions [Line Items]
Identifiable assets acquired and liabilities assumed	$ 30
Expected life	15 years
Trade Names | Royalty rate
Business Combination, Separately Recognized Transactions [Line Items]
Measurement inputs	5.00%
Customer Relationships
Business Combination, Separately Recognized Transactions [Line Items]
Identifiable assets acquired and liabilities assumed	$ 17
Expected life	14 years 6 months
Customer Relationships | Royalty rate
Business Combination, Separately Recognized Transactions [Line Items]
Measurement inputs	3.00%
Consulting Agreement
Business Combination, Separately Recognized Transactions [Line Items]
Identifiable assets acquired and liabilities assumed	$ 10
Expected life	5 years
Noncompete Agreements
Business Combination, Separately Recognized Transactions [Line Items]
Identifiable assets acquired and liabilities assumed	$ 6
Expected life	10 years

Acquisitions (Details)

Acquisitions (Details) - USD ($) $ in Thousands	Nov. 30, 2020	Feb. 29, 2020	Jan. 23, 2020
Assets
Goodwill	$ 739,901	$ 739,901
Drybar Products LLC
Assets
Receivables			$ 7,710
Inventory			16,603
Prepaid expenses and other current assets			190
Property and equipment			1,472
Goodwill			172,933
Subtotal - assets			261,908
Liabilities [Abstract]
Accounts payable			1,948
Accrued expenses			4,099
Subtotal - liabilities			6,047
Net assets recorded			255,861
Drybar Products LLC | Trade Names
Assets
Definite lived intangible assets			30,000
Drybar Products LLC | Other intangibles - finite
Assets
Definite lived intangible assets			$ 33,000

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of carrying amounts and associated accumulated amortization for all intangible assets by operating segment (Details) - USD ($) $ in Thousands	Nov. 30, 2020	Feb. 29, 2020
Changes in Goodwill
Cumulative goodwill impairments	$ 0	$ (71,993)
Goodwill net book value	739,901	739,901
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, accumulated amortization	(162,425)	(148,891)
Goodwill and intangible assets
Gross carrying amount	1,190,943	1,311,122
Intangible assets, net (including goodwill)	1,028,518	1,040,853
Other Intangible Assets, Including Held-For-Sale
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, accumulated amortization		(198,276)
Housewares
Changes in Goodwill
Goodwill gross carrying amount	282,056	282,056
Cumulative goodwill impairments	0	0
Goodwill net book value	282,056	282,056
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, accumulated amortization	(23,011)	(21,469)
Goodwill and intangible assets
Gross carrying amount	459,319	458,351
Intangible assets, net (including goodwill)	436,308	436,882
Housewares | Other intangibles - finite
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	43,063	42,095
Intangible assets - finite-lived, accumulated amortization	(23,011)	(21,469)
Intangible assets - finite-lived, net book value	20,052	20,626
Housewares | Trademarks
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	134,200	134,200
Health & Home
Changes in Goodwill
Goodwill gross carrying amount	284,913	284,913
Cumulative goodwill impairments	0	0
Goodwill net book value	284,913	284,913
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, accumulated amortization	(121,308)	(113,894)
Goodwill and intangible assets
Gross carrying amount	481,809	481,586
Intangible assets, net (including goodwill)	360,501	367,692
Health & Home | Licenses
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	17,050	17,050
Intangible assets - finite-lived, accumulated amortization	(16,015)	(15,752)
Intangible assets - finite-lived, net book value	1,035	1,298
Health & Home | Other intangibles - finite
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	118,446	118,223
Intangible assets - finite-lived, accumulated amortization	(105,293)	(98,142)
Intangible assets - finite-lived, net book value	13,153	20,081
Health & Home | Trademarks
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	54,000	54,000
Health & Home | Licenses
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	7,400	7,400
Beauty
Changes in Goodwill
Goodwill gross carrying amount	172,932	244,925
Cumulative goodwill impairments	0	(71,993)
Goodwill net book value	172,932	172,932
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, accumulated amortization	(18,106)	(62,913)
Goodwill and intangible assets
Gross carrying amount	249,815	371,185
Intangible assets, net (including goodwill)	231,709	236,279
Beauty | Other intangibles - finite
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, accumulated amortization		(49,400)
Beauty | Trademarks
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	30,151	33,392
Intangible assets - finite-lived, accumulated amortization	(1,827)	(3,564)
Intangible assets - finite-lived, net book value	28,324	29,828
Beauty | Licenses
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	13,697	13,697
Intangible assets - finite-lived, accumulated amortization	(13,037)	(12,800)
Intangible assets - finite-lived, net book value	660	897
Beauty | Other intangibles - finite
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	33,035	79,171
Intangible assets - finite-lived, accumulated amortization	(3,242)	(46,549)
Intangible assets - finite-lived, net book value	$ 29,793	$ 32,622

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Summary of amortization expense attributable to intangible assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 4,501	$ 4,790	$ 13,527	$ 13,129

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Schedule of estimated amortization expense of intangible assets (Details) $ in Thousands	Nov. 30, 2020USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Fiscal 2021	$ 16,751
Fiscal 2022	10,361
Fiscal 2023	10,287
Fiscal 2024	9,902
Fiscal 2025	9,281
Fiscal 2026	$ 7,252

Share-Based Compensation Plan_2

Share-Based Compensation Plans (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	9 Months Ended
	Nov. 30, 2020	Nov. 30, 2020
Share-based compensation plans
Exercise of stock options (in shares)	850	13,540
Employee purchases of common stock (in shares)	12,264	26,830
Average purchase price (in dollars per share)	$ 139.88	$ 134.78
Directors stock compensation
Share-based compensation plans
Number of awards granted (in shares)	770	2,842
Grant date fair value	$ 0.1	$ 0.5
Grant date fair value of shares granted in period (in dollars per share)	$ 207.98	$ 184.56
Performance Restricted Stock Units (PSU)
Share-based compensation plans
Number of awards granted (in shares)	0	4,970
Grant date fair value		$ 0.8
Grant date fair value of shares granted in period (in dollars per share)		$ 170.27
Performance Based Restricted Stock Awards (PSA)
Share-based compensation plans
Number of awards granted (in shares)	0	86,004
Grant date fair value		$ 14.6
Grant date fair value of shares granted in period (in dollars per share)		$ 170.27
Time-Vested | Restricted Stock Units (RSU)
Share-based compensation plans
Number of awards granted (in shares)	39	2,747
Grant date fair value		$ 0.5
Grant date fair value of shares granted in period (in dollars per share)	$ 200	$ 170.69
Time-Vested | Restricted Stock Awards (RSA)
Share-based compensation plans
Number of awards granted (in shares)	4,171	42,143
Grant date fair value	$ 0.8	$ 7.3
Grant date fair value of shares granted in period (in dollars per share)	$ 199.39	$ 174.03
Vested and settled performance shares | Restricted Stock Units (RSU)
Share-based compensation plans
Grant date fair value	$ 3.6	$ 11.3
Shares vested and settled (in shares)	18,196	64,948
Grant date fair value of shares settled in period (in dollars per share)	$ 195.29	$ 173.33
Vested and settled performance shares | Restricted Stock Awards (RSA)
Share-based compensation plans
Grant date fair value	$ 0.1	$ 1.4
Shares vested (in shares)	605	7,929
Grant date fair value of shares settled in period (in dollars per share)	$ 201.29	$ 174.75
Vested and settled performance shares | Performance Restricted Stock Units (PSU)
Share-based compensation plans
Grant date fair value		$ 18.6
Shares vested and settled (in shares)	0	112,720
Grant date fair value of shares settled in period (in dollars per share)		$ 164.58

Share-Based Compensation Plan_3

Share-Based Compensation Plans Share Based Compensation Expense in SG&A (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense, net of income tax benefits	$ 6,336	$ 4,415	$ 19,248	$ 17,309
Impact of share-based compensation on EPS:
Basic (in dollars per share)	$ 0.25	$ 0.18	$ 0.76	$ 0.69
Diluted (in dollars per share)	$ 0.25	$ 0.17	$ 0.76	$ 0.68
SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 6,739	$ 4,758	$ 20,654	$ 18,743
Less income tax benefits	(403)	(343)	(1,406)	(1,434)
Stock options | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	3	21	18	172
Performance based and other stock awards | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	6,084	4,138	19,134	17,366
Employee stock purchase plan | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	491	459	977	784
Directors stock compensation | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 161	$ 140	$ 525	$ 421

Repurchase of Helen of Troy C_2

Repurchase of Helen of Troy Common Stock (Details) - USD ($)	May 08, 2019	Nov. 30, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019	Aug. 31, 2019
Repurchase of common stock
Amount of shares authorized for purchase						$ 400,000,000
Period for stock repurchase	3 years
Remaining share repurchase amount - prior program	$ 107,400,000
Remaining share repurchase amount		$ 190,000,000		$ 190,000,000
Repurchase of common stock
Aggregate value of shares		$ 192,800,000	$ 1,002,000	$ 202,961,000	$ 10,133,000
Open Market And Tender Offer
Repurchase of common stock
Number of shares (in shares)		960,829	0	960,829	0
Aggregate value of shares		$ 191,606,000	$ 0	$ 191,606,000	$ 0
Average price per share (in dollars per share)		$ 199.42	$ 0	$ 199.42	$ 0
Stock Compensation Plan
Repurchase of common stock
Number of shares (in shares)		6,115,000	6,509,000	67,740,000	77,067,000
Aggregate value of shares		$ 1,194,000	$ 1,002,000	$ 11,355,000	$ 10,133,000
Average price per share (in dollars per share)		$ 195.26	$ 153.88	$ 167.63	$ 131.48

Restructuring Plan (Details)

Restructuring Plan (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		41 Months Ended
	Nov. 30, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019	Feb. 28, 2021
Restructuring Plan
Restructuring charges	$ (12)	$ 12	$ 355	$ 1,061
Cash restructuring payments for the reporting period	200	$ 300	900	$ 1,800
Project Refuel
Restructuring Plan
Restructuring charges			400
Incurred pre-tax restructuring costs	9,100		9,100
Cash restructuring payments to date			8,900
Restructuring liability	$ 200		$ 200
Scenario, Forecast | Project Refuel
Restructuring Plan
Expected restructuring costs					$ 9,500
Scenario, Forecast | Minimum | Project Refuel
Restructuring Plan
Targeted annualized profit improvement					9,000
Scenario, Forecast | Maximum | Project Refuel
Restructuring Plan
Targeted annualized profit improvement					$ 11,000

Long-Term Debt - Schedule (Deta

Long-Term Debt - Schedule (Details) - USD ($)	Mar. 13, 2020	Nov. 30, 2020	Aug. 31, 2020	Nov. 30, 2020	Feb. 29, 2020
Long-term debt
Increase in accordion feature	$ 300,000,000		$ 200,000,000
Maximum additional debt allowed under debt covenants		$ 804,800,000		$ 804,800,000
Remaining principal balance due on March 1, 2022		$ 1,900,000		$ 1,900,000
Minimum | Base rate
Long-term debt
Interest rate	0.00%
Minimum | Eurodollar
Long-term debt
Interest rate	1.00%
Maximum | Base rate
Long-term debt
Interest rate	1.00%
Maximum | Eurodollar
Long-term debt
Interest rate	2.00%
Credit agreement
Long-term debt
Maximum revolving commitment	$ 1,250,000,000				$ 1,000,000,000
Credit agreement | Minimum
Long-term debt
Interest rate range during the period (as a percent)		1.14%		1.14%
Credit agreement | Maximum
Long-term debt
Interest rate range during the period (as a percent)		3.25%		4.75%
MBFC loan
Long-term debt
Amount available for borrowings		$ 804,800,000		$ 804,800,000
Aggregate principal balance		18,600,000		18,600,000
Remaining principal balance due on March 1, 2021		1,900,000		1,900,000
Remaining principal balance due on March 1, 2022		1,900,000		1,900,000
Remaining principal balance due on March 1, 2023		14,800,000		$ 14,800,000
MBFC loan | Base rate
Long-term debt
Interest rate				1.00%
Revolving loan | Credit agreement
Long-term debt
Amount outstanding		426,000,000		$ 426,000,000
Letter of credit | Credit agreement
Long-term debt
Amount outstanding		$ 19,200,000		$ 19,200,000

Long-Term Debt - Summary of lon

Long-Term Debt - Summary of long-term debt (Details) - USD ($) $ in Thousands	Mar. 13, 2020	Nov. 30, 2020	Feb. 29, 2020
Debt Instrument [Line Items]
Long-term debt		$ 440,381	$ 339,305
Less current maturities of long-term debt		(1,884)	(1,884)
Long-term debt, excluding current maturities		438,497	337,421
Remaining principal balance due on March 1, 2022		1,900
Base rate | Minimum
Debt Instrument [Line Items]
Interest rate	0.00%
Base rate | Maximum
Debt Instrument [Line Items]
Interest rate	1.00%
Credit agreement
Debt Instrument [Line Items]
Long-term debt		421,833	318,854
Amount of interest rate swap hedge		225,000
MBFC loan
Debt Instrument [Line Items]
Long-term debt		18,548	$ 20,451
Remaining principal balance due on March 1, 2021		1,900
Remaining principal balance due on March 1, 2022		1,900
Remaining principal balance due on March 1, 2023		$ 14,800
MBFC loan | LIBOR | Maximum
Debt Instrument [Line Items]
Interest rate		2.00%
MBFC loan | Base rate
Debt Instrument [Line Items]
Interest rate		1.00%

Fair Value (Details)

Fair Value (Details) - Recurring - Fair Values - Significant other observable market inputs (Level 2) - USD ($) $ in Thousands	Nov. 30, 2020	Feb. 29, 2020
Assets:
Total assets	$ 118,566	$ 4,731
Liabilities:
Total liabilities	457,336	350,181
Interest rate swap
Assets:
Derivative assets	0	0
Liabilities:
Derivative assets	11,627	10,717
Foreign currency contracts
Assets:
Derivative assets	7	2,083
Liabilities:
Derivative assets	5,328	159
Floating rate debt
Liabilities:
Floating rate debt	440,381	339,305
Money market accounts
Assets:
Money market accounts	$ 118,559	$ 2,648

Financial Instruments and Ris_3

Financial Instruments and Risk Management (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 30, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019
Revolving loan | Credit agreement
Foreign Currency Risk and Currency Exchange Uncertainties
Amount outstanding	$ 426		$ 426
SG&A
Foreign Currency Risk and Currency Exchange Uncertainties
Net foreign exchange gains (losses), including the impact of currency hedges and currency swaps	$ 0.4	$ 0.6	$ 0.5	$ 2.2
Net sales revenue | Geographic concentration | International operations - transactions denominated in foreign currencies
Foreign Currency Risk and Currency Exchange Uncertainties
Concentration risk percentage	11.00%	17.00%	12.00%	14.00%

Financial Instruments and Ris_4

Financial Instruments and Risk Management - Interest Rate Risk (Details) $ in Millions	Nov. 30, 2020USD ($)
Credit agreement
Financial instruments and risk management
Fixed rate debt	$ 225

Financial Instruments and Ris_5

Financial Instruments and Risk Management - Derivative FV (Details) € in Thousands, £ in Thousands, $ in Thousands, $ in Thousands, $ in Thousands	Nov. 30, 2020EUR (€)	Nov. 30, 2020USD ($)	Nov. 30, 2020CAD ($)	Nov. 30, 2020GBP (£)	Nov. 30, 2020MXN ($)	Feb. 29, 2020EUR (€)	Feb. 29, 2020USD ($)	Feb. 29, 2020CAD ($)	Feb. 29, 2020GBP (£)	Feb. 29, 2020MXN ($)
Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		$ 7					$ 2,060
Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					23
Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		8,306					3,633
Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		8,649					7,243
Derivatives designated as hedging instruments | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		7					1,560
Derivatives designated as hedging instruments | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					23
Derivatives designated as hedging instruments | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		8,306					3,633
Derivatives designated as hedging instruments | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		7,433					7,243
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros
Fair values of derivative instruments in the consolidated balance sheet
Notional amount | €	€ 46,000					€ 25,875
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					837
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		1,758					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		433					15
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars
Fair values of derivative instruments in the consolidated balance sheet
Notional amount			$ 26,000					$ 14,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					202
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		763					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		93					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds
Fair values of derivative instruments in the consolidated balance sheet
Notional amount | £				£ 23,790					£ 13,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					435
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					23
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		662					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		266					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos
Fair values of derivative instruments in the consolidated balance sheet
Notional amount					$ 30,000					$ 10,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		7					12
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives designated as hedging instruments | Zero-cost collar contract | Sell | Euros
Fair values of derivative instruments in the consolidated balance sheet
Notional amount | €	2,000					8,000
Derivatives designated as hedging instruments | Zero-cost collar contract | Sell | Euros | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					74
Derivatives designated as hedging instruments | Zero-cost collar contract | Sell | Euros | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					0
Derivatives designated as hedging instruments | Zero-cost collar contract | Sell | Euros | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		15					0
Derivatives designated as hedging instruments | Zero-cost collar contract | Sell | Euros | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives designated as hedging instruments | Zero-cost collar contract | Sell | Pounds
Fair values of derivative instruments in the consolidated balance sheet
Notional amount | £				2,000					6,500
Derivatives designated as hedging instruments | Zero-cost collar contract | Sell | Pounds | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					0
Derivatives designated as hedging instruments | Zero-cost collar contract | Sell | Pounds | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					0
Derivatives designated as hedging instruments | Zero-cost collar contract | Sell | Pounds | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		122					144
Derivatives designated as hedging instruments | Zero-cost collar contract | Sell | Pounds | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives designated as hedging instruments | Interest rate swaps
Fair values of derivative instruments in the consolidated balance sheet
Notional amount		225,000					225,000
Derivatives designated as hedging instruments | Interest rate swaps | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					0
Derivatives designated as hedging instruments | Interest rate swaps | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					0
Derivatives designated as hedging instruments | Interest rate swaps | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		4,986					3,489
Derivatives designated as hedging instruments | Interest rate swaps | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		6,641					7,228
Derivatives not designated under hedge accounting | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					500
Derivatives not designated under hedge accounting | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					0
Derivatives not designated under hedge accounting | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives not designated under hedge accounting | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		1,216					0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros
Fair values of derivative instruments in the consolidated balance sheet
Notional amount | €	€ 6,000					€ 4,400
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					473
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		732					0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds
Fair values of derivative instruments in the consolidated balance sheet
Notional amount | £				£ 4,500					£ 5,000
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					27
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		$ 484					$ 0

Financial Instruments and Ris_6

Financial Instruments and Risk Management - Derivative tax effect (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in AOCI	$ 3,089	$ (655)	$ (6,563)	$ (10,649)
Gain (Loss) Reclassified from AOCI into Income	549	(630)	(124)	(2,840)
Gain (Loss) Recognized in Income	(1,268)	(478)	(4,225)	635
Foreign currency contracts | SG&A
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in Income	0	0	0	0
Foreign currency contracts | Cash flow hedges
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in AOCI	1,550	(2,739)	(5,653)	(3,407)
Net loss currently reported in accumulated other comprehensive income, to be reclassified into income			$ 8,300
Net loss currently reported in accumulated other comprehensive income, to be reclassified into income, period of time to transfer			12 months
Foreign currency contracts | Cash flow hedges | SG&A
Pre-tax effect of derivative instruments
Gain (Loss) Reclassified from AOCI into Income	549	(630)	$ (124)	(2,840)
Interest rate swaps | Interest expense
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in Income	(1,289)	(162)	(3,222)	69
Interest rate swaps | Cash flow hedges
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in AOCI	1,539	2,084	(910)	(7,242)
Interest rate swaps | Cash flow hedges | Interest expense
Pre-tax effect of derivative instruments
Gain (Loss) Reclassified from AOCI into Income	0	0	0	0
Cross currency debt swaps
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in AOCI	0	0	0	0
Gain (Loss) Reclassified from AOCI into Income	0	0	0	0
Cross currency debt swaps | SG&A
Pre-tax effect of derivative instruments
Gain (Loss) Reclassified from AOCI into Income	0	0	0	0
Gain (Loss) Recognized in Income	23	(389)	(1,075)	419
Cross currency debt swaps | Interest expense
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in Income	$ (2)	$ 73	$ 72	$ 147

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 1,308,529	$ 1,087,375	$ 1,161,723	$ 996,637
Other comprehensive loss before reclassification			(6,563)	(10,649)
Amounts reclassified out of AOCI			124	2,840
Tax effects			1,159	1,733
Total other comprehensive income (loss), net of tax	2,035	(130)	(5,280)	(6,076)
Ending balance	1,210,438	1,161,684	1,210,438	1,161,684
Interest Rate Swaps
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			(8,199)	132
Other comprehensive loss before reclassification			(910)	(7,242)
Amounts reclassified out of AOCI			0	0
Tax effects			214	1,680
Total other comprehensive income (loss), net of tax			(696)	(5,562)
Ending balance	(8,895)	(5,430)	(8,895)	(5,430)
Foreign Currency Contracts
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			1,194	1,059
Other comprehensive loss before reclassification			(5,653)	(3,407)
Amounts reclassified out of AOCI			124	2,840
Tax effects			945	53
Total other comprehensive income (loss), net of tax			(4,584)	(514)
Ending balance	(3,390)	545	(3,390)	545
Total
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(14,320)	(4,755)	(7,005)	1,191
Total other comprehensive income (loss), net of tax	2,035	(130)	(5,280)	(6,076)
Ending balance	$ (12,285)	$ (4,885)	$ (12,285)	$ (4,885)

Segment Information (Details)

Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019
Segment information
Sales revenue, net	$ 637,737	$ 474,737	$ 1,589,424	$ 1,265,067
Restructuring charges	(12)	12	355	1,061
Operating income	100,709	79,269	256,963	180,996
Capital and intangible asset expenditures	4,186	4,386	19,423	13,247
Depreciation and amortization	9,519	8,760	27,995	24,876
Housewares
Segment information
Sales revenue, net	222,400	183,211	564,891	496,017
Restructuring charges	(12)	0	251	90
Operating income	37,658	42,272	106,294	109,170
Capital and intangible asset expenditures	1,375	2,272	6,912	8,354
Depreciation and amortization	2,371	2,263	6,743	5,292
Health & Home
Segment information
Sales revenue, net	250,158	185,810	661,568	499,543
Restructuring charges	0	0	0	0
Operating income	30,478	24,372	95,782	51,836
Capital and intangible asset expenditures	2,441	1,917	10,346	4,115
Depreciation and amortization	4,106	3,740	12,331	12,322
Beauty
Segment information
Sales revenue, net	165,179	105,716	362,965	269,507
Restructuring charges	0	12	104	971
Operating income	32,573	12,625	54,887	19,990
Capital and intangible asset expenditures	370	197	2,165	778
Depreciation and amortization	$ 3,042	$ 2,757	$ 8,921	$ 7,262

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	Dec. 04, 2020	May 31, 2022	Nov. 30, 2020	May 31, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019	Feb. 28, 2022	Feb. 28, 2019
Income Tax Contingency [Line Items]
Income tax expense (benefit) as a percent of income before income taxes			14.00%		10.30%	6.50%	9.60%
One time tax charge required due to Tax Act									$ 17,900
Income tax expense			$ 13,721		$ 7,895	$ 16,061	$ 16,530		$ 9,400
Subsequent Event
Income Tax Contingency [Line Items]
Settlement amount of disputed tax assessment	$ 500
State and Local Jurisdiction | Subsequent Event
Income Tax Contingency [Line Items]
Amount of disputed tax assessment	$ 6,000
Foreign Tax Authority | Scenario, Forecast | Minimum
Income Tax Contingency [Line Items]
Percent increase in overall effective tax rate due to changes in Macau Offshore Law								1.50%
Foreign Tax Authority | Scenario, Forecast | Maximum
Income Tax Contingency [Line Items]
Percent increase in overall effective tax rate due to changes in Macau Offshore Law		2.00%
COVID-19
Income Tax Contingency [Line Items]
One-time income tax benefit, CARES Act				$ 9,400

Earnings per Share (Details)

Earnings per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019
Weighted average diluted securities
Weighted average shares outstanding, basic (in shares)	24,965	25,161	25,182	25,099
Incremental shares from share-based payment arrangements (in shares)	227	235	168	196
Weighted average shares outstanding, diluted (in shares)	25,192	25,396	25,350	25,295
Stock options
Weighted average diluted securities
Antidilutive securities (in shares)	4	134	149	217

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event - Trademarks - Revlon $ in Millions	Dec. 22, 2020USD ($)renewal
Subsequent Event [Line Items]
Initial term of licensing agreement	40 years
Number of renewal terms | renewal	3
Term of trademark license renewal	20 years
Up-front license fee | $	$ 72.5
License fee amortization period	40 years

Uncategorized Items - hele-2020

Label	Element	Value
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	$ 37,082,000
Non-Cash Increase (Decrease) In Other Accrued Liabilities	hele_NonCashIncreaseDecreaseInOtherAccruedLiabilities	(2,873,000)
Non-Cash Increase (Decrease) In Other Current Assets And Liabilities, Net	hele_NonCashIncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet	(7,311,000)
Non-Cash Increase (Decrease) In Prepaid Expense And Other Assets	hele_NonCashIncreaseDecreaseInPrepaidExpenseAndOtherAssets	$ 43,000